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Acronyms and Definitions
ACRONYMS
ALHIV 		

Adolescents living with HIV

aOR		

Adjusted odds ratio

aHR		

Adjusted hazard ratio

CDC 		

The Centers for Disease Control and Prevention

CHAMP		

Collaborative HIV Prevention and Adolescent Mental Health Family Program

CI		

Confidence intervals

HTC		

HIV testing and counseling

IQR		

Interquartile range

LTFU		

Lost to follow-up

OR		

Operations research

PEPFAR		

United States President’s Emergency Plan for AIDS Relief

PITC		

Provider initiated testing and counseling

PLHIV		

People living with HIV

PMTCT		

Prevention of mother-to-child transmission

STI		

Sexually transmitted infections

SSA 		

Sub-Saharan Africa

TASO		

The AIDS Support Organization

UNICEF		

United Nations International Children’s Emergency Fund

UNAIDS		

Joint United Nations Programme on HIV/AIDS

USAID		

United States Agency for International Development

VCT		

Voluntary counseling and testing

VL		

Viral load

WHO		

World Health Organization
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DEFINITIONS
The following definitions are used in this paper:

Adolescence
The World Health Organization (WHO) defines adolescence as the period between childhood
and adulthood that encompasses 10 to 19 year olds, which is marked by intense growth and
development (WHO 2015a). Adolescents undergo changes in physical, cognitive (e.g., moving
from concrete to abstract thinking) and psychological development (e.g., emotional maturity) and
take on new and expanded social roles and responsibilities (Sanders 2013). In recognition that
adolescence is a developmental process and that a 10 year old may be at a very different point
of development compared to a 19 year old, adolescence is often further categorized into early
(10–13 years), middle (14–16 years), and late (17–19 years) stages (Sawyer et al. 2012; WHO
2015d). While these age definitions help to focus attention on the second decade of life, the
actual beginning and end of adolescence varies across individuals, cultures, and countries with
the onset of puberty typically marking the beginning of adolescence and other markers (e.g., age
of legal majority, rites of passage, marriage) indicating the end.

HIV care continuum
The HIV care continuum (sometimes also called the HIV treatment cascade) is a model that
delineates the sequential steps or stages of medical care that persons living with HIV (PLHIV) go
through from initial diagnosis and engagement in care to achieving the goal of viral suppression,
showing the proportion of PLHIV who are engaged at each step of care (AIDS.ORG 2015). It
is a tool designed to identify where efforts are needed to improve HIV outcomes. The Centers
for Disease Control and Prevention (CDC) specifically defines and tracks the following steps
of the care continuum: diagnosis, linkage to care, retained in care, prescribed ART and virally
suppressed (CDC 2014). This paper uses a slightly modified framework to examine the HIV care
outcomes among adolescents living with HIV (ALHIV) with an emphasis on the factors and service
delivery approaches related to each step along the continuum:
• Identifying ALHIV through testing and counseling.
• Linking ALHIV to HIV care.
• Retaining ALHIV in care.
• ALHIV adhering to ART and achieving viral load suppression.
• ALHIV transitioning to adult care and self-management.

Implementation science
Under PEPFAR, an implementation science framework consists of three key components:
operations research (OR), routine monitoring and evaluation, and focused impact evaluations
(Kerrigan et al. 2015; Padian et al. 2011). Within this framework, the purpose of OR, and the
focus of the Technical Advisory Network meeting, is to generate evidence that will improve the
efficiency, effectiveness, and quality of services delivered, and the availability, accessibility, and
acceptability of the service for the users (Fisher et al. 2002). One definition of OR describes this
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focus on service delivery as a continuous process that consists of five main steps: (1) problem
identification and diagnosis; (2) strategy selection; (3) strategy testing and evaluation; (4)
information dissemination; and (5) information utilization (Fisher et al. 2002).

Adolescent-friendly services
The World Health Organization has identified eight global standards for delivering quality healthcare services for adolescents (WHO 2015c). These standards include: (1) adolescents’ health
literacy (knowledge about one’s health), (2) community support (including parent/guardian
support), (3) appropriate package of services (that fulfills the needs of all adolescents and
includes facility services and services provided through referrals and outreach), (4) providers’
competencies (e.g., privacy, non-judgmental, respect), (5) facility characteristics (e.g., convenient
operating hours), (6) equity and non-discrimination, (7) data and quality improvement, and (8)
adolescents’ participation in the planning, monitoring and evaluation of health services, including
their participation in decisions regarding their own care.
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Introduction
Significant advances have occurred in the field of HIV prevention, treatment, and care in recent
years. However, progress for the estimated 2.1 million adolescents living with HIV (ALHIV) has
been less than optimal (UNAIDS 2014; UNAIDS and WHO 2013). AIDS is currently the leading
cause of death among adolescents in sub-Saharan Africa (SSA) and the second leading cause of
death globally (Dick and Ferguson 2015). AIDS-related deaths are declining in every age group
except 10–19 years old. Additionally, only one in four infected children under the age of 15 has
access to antiretroviral therapy (ART) (UNAIDS 2013).
Several new initiatives have recently been formed to respond to this crisis including the “All In”
initiative led by UNAIDS, UNICEF, and partners such as PEPFAR. As more attention and resources
are focused on ALHIV, it is critical that a strategic implementation science research agenda
parallels these efforts. Project SOAR, a USAID-supported global operations research project,
implemented by a multi-partner consortium of expert institutions, is in a unique place to bring
together leaders in the field to strategize and recommend priority research questions, which if
answered, will improve HIV outcomes for adolescents.
On 18–19 February 2016, Project SOAR convened a Technical Advisory Network meeting in
Washington DC, “Developing an Implementation Science Research Agenda to Improve the
Treatment and Care Outcomes among Adolescents Living with HIV in sub-Saharan Africa.”
More than 50 international and domestic thought leaders in adolescent HIV care research and
programming participated in the meeting together with a small group of youth from southern
Africa who are living with HIV. To prepare the groundwork for the meeting, SOAR produced a
background paper synthesizing the literature on HIV continuum of care outcomes among ALHIV in
SSA, where most adolescent cases of HIV are concentrated. The care continuum encompasses:
• Identifying ALHIV through testing.
• Linking ALHIV to HIV care.
• Retaining ALHIV in care.
• ALHIV adhering to ART and achieving viral load suppression.
• ALHIV transitioning to adult care and self-management.
This report presents the findings from the literature review and highlights from the Technical
Advisory Network meeting. The first section is a summary of the review’s findings, specifically
what we know about ALHIV along the care continuum. The complete literature review is found in
Appendix 1.
The second section of the report summarizes the outcomes from the meeting, including a set of
priority research questions for the larger HIV community, as well as for Project SOAR, to consider
addressing as part of new or ongoing studies. See Appendices 2 and 3 for the meeting agenda
and the participant list, respectively.
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After the meeting, USAID asked Project SOAR to conduct a literature review on prevention of
mother-to-child transmission outcomes among ALHIV. The results from this review are found in
Appendix 4.
By consolidating existing knowledge about ALHIV along the care continuum and documenting the
research priorities identified by global experts, this report can serve as an important resource for
catalyzing implementation research that fills important gaps in addressing ALHIV’s unique needs.
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Literature Review: A Summary
We conducted a review of the published literature by searching PubMed using terms such as HIV,
adolescent, Africa, and adherence. Abstracts were reviewed and articles pulled to assess if they
met the eligibility criteria, including having: (1) data on a HIV continuum of care outcome, (2) a
study sample from SSA, and (3) data on adolescents with a mean or median age between the
ages of 10 and 19 years. Given the existing systematic reviews and meta-analyses on the care
continuum (e.g., systematic reviews on adherence among adolescents and children), we searched
PubMed for new articles published between 1 January 2014 and 10 March 2016 to capture
new manuscripts published after these previous reviews’ inclusion dates. The grey literature was
not systematically searched, however, reports and guidance were pulled from sources such as
AIDSSTAR and the websites of USAID’s implementing partners. In sum, we found and used the
following papers:
• Testing/linkage to care: two systematic reviews, one with 15 age-eligible studies on HIV testing
and one with one study on linkages to care, plus three additional studies identified through
PubMed and the grey literature.
• Retention: one systematic review with one age-eligible study, plus nine additional studies
identified through PubMed and the grey literature.
• Adherence: five systematic reviews identified 20 unique age-eligible studies, plus 16 additional
studies identified through PubMed and the grey literature.
• Transitioning to adult care and self-management: one review article found no studies based in
SSA, and no studies were identified through PubMed.
Below is a summary of our findings from the literature. As noted above, the entire literature review
can be found in Appendix 1.

EPIDEMIOLOGY OF HIV AMONG ADOLESCENTS IN SUBSAHARAN AFRICA
An estimated 85 percent of the 2.1 million adolescents living with HIV reside in SSA with about
1.3 million in East and Southern Africa and 390,000 in West and Central Africa (Idele et al.
2014). Just six countries, five in SSA plus India, account for half of the world’s HIV-infected
adolescents (Kasedde 2015).
Among younger adolescents (age 10–14 years), prevalence among males and females is fairly
even across countries in SSA, likely reflecting that a majority of these infections were acquired
through mother to child transmission of HIV. In mid and late adolescence (age 15–19 years),
when sexual transmission of HIV becomes a predominant mode of acquisition among ALHIV,
a very significant gap between the sexes emerges, with females up to two to five times more
likely to be infected than their male peers (Idele et al. 2014). This age-gender gap reflects the
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feminization of the epidemic and the biological, social, and structural factors that increase the
risk young females face in acquiring HIV through sexual transmission.
The vulnerability of key populations of youth (e.g., men who have sex with men, people who
inject drugs) is well established. The 2014 WHO guidelines on HIV among key populations states
how adolescents who are members of these groups are at even greater risk than their adult
counterparts for poorer health outcomes related to HIV, STIs, and reproductive health. Despite
this recognition of their vulnerabilities, little data on the epidemiology of adolescents who may be
members of key populations in SSA are available (Bekker, Johnson, Wallace, and Hosek 2015).

ADOLESCENTS AND THE CARE CONTINUUM
The literature review revealed that the published data on care continuum outcomes among ALHIV
in SSA are sparse, particularly age-disaggregated data on linking positive youth to care and on
transitioning adolescents to self-care and adult HIV clinics. In addition to this general lack of data
on ALHIV in SSA, there is even less evidence on program approaches that support ALHIV and their
families as they cope with testing for HIV, linking to care, remaining in care, adhering to ART, and
transitioning to adulthood and self-management. We also were unable to find any adolescent
specific data in the published literature on HIV care continuum outcomes among adolescents in
SSA who are members of key populations.
Below we summarize the major findings from the literature on each component of the care
continuum.

Identifying ALHIV through HIV Testing and Counseling
HIV testing and counseling (HTC) is a critical entry point to care and treatment, however only
an estimated 29 percent of females and 20 percent of males between 15 and 19 years of age
in Eastern and Southern Africa have ever taken an HIV test and know their HIV status (UNICEF
2013). Many countries have policies and laws restricting adolescent access to testing in clinic
settings, including parental consent requirements, creating barriers to testing for sexually active
young people who wish to learn their HIV status (WHO 2013, Annex 15; Sam-Aguda, et al. 2016).

Home-based testing has been shown to have the highest uptake among
adolescents, but provider-initiated testing and counseling has identified the greatest
proportion of ALHIV.
A systematic review of HIV testing among adolescents found 15 eligible studies with data from
SSA. These studies examined provider-initiated, outreach, home-based, and family centered
HTC. Adolescent uptake was highest with home-based testing (86–99 percent), but detection
of positives ranged only from 0.5–3 percent. Uptake varied widely for provider-initiated testing
and counseling (40.7–95.5 percent), but it identified the highest proportion of HIV-positive
adolescents (6–23 percent) (Govindasamy et al. 2015).
A study comparing mobile HTC with home-based HTC in rural Swaziland found that two percent
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of adolescents reached through both approaches tested positive for HIV (Parker et al. 2015).
While the overall percentage of positives identified through community-based strategies may
be relatively small, community-based approaches may be more successful in diagnosing HIV
infection earlier in adolescence, leading to better health outcomes (Govindasamy et al. 2015).

Three home-based testing studies that required parental/guardian consent for
adolescents to test demonstrated high levels of uptake.
Requiring parental or guardian consent is a potential barrier to accessing testing, care, and
treatment in adolescence. Moreover, the process of obtaining consent can be unclear and pose
a challenge for health care providers (Govindasamy et al. 2015; Kranzer et al. 2014). Yet three
of the home-based testing studies included in the systematic review (Govindasamy et al. 2015)
required parental or guardian consent for younger adolescents to participate and still yielded
high uptake (85.8–93.6 percent) (Angotti et al. 2009; Dalal et al. 2013; Naik, Tabana, Doherty,
Zembe, and Jackson 2012). In addition, the one outreach study that clearly called for parental or
guardian consent also had a high proportion accept to undergo testing (90.2 percent). These high
levels of parent consent and subsequent adolescent uptake in home-based testing programs may
differ greatly from clinic-based testing where parental consent may act as a barrier for sexually
active adolescents seeking to learn their HIV status (WHO 2013, Annex 15).

Linking and Retaining ALHIV in Care
Very limited data are available on the process of linking adolescents who test positive to HIV care
and treatment. A 2015 review found only one eligible article on linkages to care (MacPherson
et al. 2015), with most of the available data focusing on ART initiation among adolescents once
enrolled in care. Published findings are not yet available on linking ALHIV to care that reflect
WHO’s 2015 revised guidelines that eliminated CD4 eligibility requirements for starting ART (Idele
et al. 2014; WHO 2015).

Many adolescents testing positive in Ugandan and South African studies did not
enroll in HIV care.
While the proportion of HIV-positive adolescents enrolling in care increased during the first
four years of TASO’s home-based HTC program (from 9 percent to 41 percent), it dropped to
20 percent by 2010 (Livingstone et al. 2014). In South Africa, out of 11,522 adolescents and
young adults (15–24 years of age) seen in a stand-alone clinic developed specifically to provide
adolescents with HIV management services, 3.6 percent tested positive for HIV (N = 410). Around
25 percent of these youth did not return to enroll in care or have a CD4 cell test conducted (Nkala
et al. 2015).

Older ALHIV appear to have poorer pre- and post-ART retention than younger ALHIV.
In a Kenyan study of pre-ART retention, an estimated 20 percent of 10–14 year olds and 44
percent of 15–19 year olds (and 49 percent of 15–24 year olds) were lost to follow up (LTFU)
12 months after enrolling in HIV care, indicating poorer retention among older vs. younger
adolescents. Clinic data from 160 clinics in Kenya, Mozambique, Tanzania, and Rwanda found
that youth ages 15–24 were at greater risk of attrition compared to young adolescents ages 10–
14 years (Lamb et al. 2014).
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A study of 8,016 young people from 109 clinics in Kenya who had initiated ART found that young
adolescents (10–14 years) had lower levels of LTFU at 12 months and 24 months compared
to 15–19 year olds (Koech et al. 2014). Data from cohorts in Zimbabwe and South Africa also
found that older adolescents experienced greater LTFU compared to younger adolescents, and
in Ethiopia adolescents ages 11–19 years were more than twice as likely to be LTFU compared
to children (10 years or younger). Some authors discuss how older adolescents may not have the
same level of caregiver involvement as younger adolescents and children, contributing to these
differences in LTFU by age.

There is a lack of evidence on interventions or program approaches to link or keep
adolescents in care.
The 2014 multi-country study by Lamb et al. found no evidence that offering adolescent-specific
clinic hours, peer educators, or support groups decreased the risk of attrition among HIV-positive
youth, ages 15–24, prior to ART initiation. The authors hypothesize that in the pre-ART phase
youth are lost soon after enrollment so they do not have time to engage in or benefit from these
types of services (Lamb et al. 2014). Yet 15–24 year olds had significantly lower post-ART attrition
if they attended clinics that provided condoms versus their peers who attended clinics that did
not provide condoms (Lamb et al. 2014). Also in a Ugandan study, adolescents who refilled their
ART at community drug distribution points were consistently at lower risk for attrition compared to
their peers refilling at health facilities at 12 months, 24 months, and 36 months (Livingstone et
al. 2014). Overall there is a paucity of data testing the effectiveness of interventions to improve
linkage to and retention in care.

ALHIV Adhering to ART and Achieving Viral Load Suppression
Five systematic review articles on ART adherence and viral load suppression identified 20 unique
studies with data on ART adherence among adolescents in SSA. Only eight of these studies
examined outcomes solely among adolescents with HIV, with more than half combining data from
adolescents with data from children and/or young adults.

Studies on ART adherence among adolescents vary greatly, based on participants’
age and the way and length of time that adherence is measured.
A systematic review by Hudelson and Cluver (2015), found nine studies in SSA who had at
least 50 percent of their study population consisting of adolescents (age range of 6 months
to 21 year; only two consisted of adolescents only). These studies generated ART adherence
estimates ranging from a low of 16 percent based on monthly self-report among 229 participants
in Zimbabwe (Mavhu et al. 2013) to a high of 94 percent using clinic-based pill count among
170 participants in Uganda (Nabukeera-Barungi, Kalyesubula, Kekitiinwa, Byakika-Tusiime, and
Musoke 2007). A 2016 literature review that included seven articles from SSA found that the
proportion of adolescents achieving viral suppression also varied greatly, ranging from 27 percent
to 89 percent at 12 months and 44 percent to 87 percent at 24 months (Ferrand et al. 2016).
The few studies that disaggregated adherence data by age found that adolescents were more
likely to have incomplete adherence and viral load failure compared to young adults.
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The majority of studies assessing factors related to adherence were cross-sectional
in design, and several had small sample sizes. These studies yielded mixed findings
about the role individual, family, and health factors play in affecting adherence
among adolescents.
A few studies have found that females are less likely to be adherent than males while others have
found the opposite. Research has revealed contrasting findings about the relationship between
a child or adolescent’s knowledge of his/her serostatus and adherence. Several studies found
associations between adherence and such family factors as caregiver relations, their involvement
in car, and knowledge about ART, while mixed results emerged regarding orphan status in
relationship to adherence. There were also mixed findings about the health of adolescents and
children and subsequent adherence to ART. It is important to note though, that several of the
studies examining adherence among adolescents in SSA were cross-sectional in design and
several had relatively small sample sizes (e.g., 82 participants), limiting the potential robustness
of the data.

There is some evidence of the positive impact of group interventions on ART
adherence by adolescents.
Few published studies provide evidence regarding effective interventions to support ART
adherence, specifically among adolescents in SSA. In Zimbabwe, data from 262 adolescents
found that participants who attended support groups had greater odds of achieving excellent
adherence compared with non-participants (Gross et al. 2015). In South Africa, 10–13 year olds
participating in six group sessions with family members had significantly greater improvements in
their adherence scores after six months than participants in the comparison arm (Bhana 2014).

ALHIV Transitioning to Adult Care and Self-management
The transition of ALHIV refers to not only the movement from a pediatric or adolescent model
to an adult model of HIV care, but also includes the development of self-management skills of
adolescents as they grow into adulthood and assume responsibility for their HIV care. Although
adolescent and pediatric services exist in SSA, many ALHIV already attend adult HIV care as this
is the only service available to them. The search did not find any published data that tested the
effectiveness of a transition model or approach among adolescents in SSA.

CONCLUSION
The published literature on the care continuum outcomes among ALHIV in SSA is sparse,
particularly age-disaggregated data linking positive youth to care and on transitioning adolescents
to self-care and adult HIV clinics. In addition, there is even less evidence on program approaches
that support ALHIV and their families as they cope with linking to and retaining in care, adhering
to ART, and transitioning into adulthood and self-management.
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Technical Advisory Network Meeting
PARTICIPANTS
On 18–19 February 2016, the USAID-funded Project SOAR convened a meeting in Washington,
DC, of more than 50 experts to focus on what we know and do not know about ALHIV along the
care continuum. The meeting aimed to identify priority research questions that, if answered,
would improve HIV policies and programs for this vulnerable population (see Appendix 2 for the
meeting agenda).
The participants represented US government agencies (CDC, HRSA, NICHD, NIMH, NIAID,
USAID), international agencies (UNICEF, WHO), non-governmental organizations (CHAI, EGPAF,
FHI360, Gates Foundation, John Snow, Population Council, Zambart), researchers from US
universities (Baylor, Columbia, Indiana University, Johns Hopkins Bloomberg School of Public
Health, University of North Carolina, University of Pennsylvania, Yale), international researchers
(Mozambique, South Africa, Uganda, Zambia, South Africa, Tanzania) and four youth living with
HIV from southern Africa (see Appendix 3 for the participant list).

PROCESS
Youth Panel: Setting the Stage
After brief introductions, the meeting began with a panel of four youth from southern Africa
who shared their experiences living with HIV and their perspectives about what helps or
hinders adolescents in getting tested, and if positive, receiving continuous care, and adhering
to treatment. All four members of the panel were perinatally infected. They highlighted the
importance of support from family and peers, having the same provider when they visit the health
center, and receiving age-appropriate explanations of their status and medication. Also critical,
as they emphasized, is working with adolescents not only to ensure adherence and achieve viral
suppression, but more broadly to provide support as they transition into adulthood and deal with
challenges around relationships, disclosure, and employment.
They also related their own negative experiences with stigma, depression, and violations of
their confidentiality. While some discussed the positive role that teachers played in supporting
them, one young woman shared how a teacher she confided in told the whole class she was HIV
positive. Throughout the meeting the three young women and one young man kept the discussion
focused on issues relevant to ALHIV.
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A Review of the Evidence and Expert Panel
Dr. Julie Denison of Johns Hopkins Bloomberg School of Public Health presented a summary
of the published quantitative evidence on care continuum outcomes among ALHIV in SSA. This
presentation was based on the findings from the comprehensive literature review undertaken
by Project SOAR and found in its entirety in Appendix 1. Following this review, an expert panel
contextualized the challenges and needs of ALHIV ranging from poor linkages to HIV care after
HIV testing to the need for global guidance on better engaging adolescents along the HIV care
continuum.

Working Groups and Selection of Priority Research Questions
The remainder of the meeting centered on four working groups:
1. HIV testing and linking ALHIV to care.
2. Retaining ALHIV in HIV care.
3. ALHIV adhering to ART and achieving viral suppression.
4. ALHIV transitioning to adult care and self-management.
Participants were allowed to choose the working group they joined, with efforts made to make
sure each group had members from government, non-government, and university settings. The
objectives of the working groups were to: (1) identify research questions for the group’s care
continuum topic; (2) select six priority research questions, using criteria provided; and (3) propose
potential study designs and platforms, such as research networks and institutions, or ongoing
studies, to build upon to answer each of the top six research questions.
The criteria for selecting a priority research question included the ability of the subsequent
research to inform the development, evaluation, or scale-up of an intervention along the care
continuum; that answering the question was feasible; and that answering the question would be
relevant not only locally but also regionally and globally.
After each group reported back to the larger meeting, all participants were asked to select their
three priority questions within each topic through silent voting with stickers. Table 1 presents the
research questions per topic in the order based on the number of votes each question received
from the whole group.
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TABLE 1 Priority research questions by care continuum topic
HIV testing/linkages to care
What are the effects and costs of a stigma reduction intervention on uptake of HIV testing
and linkage to care among adolescents?
What is the effectiveness and costs of a peer navigator model in improving linkage to care
rates in the context of a community-based or mobile testing program?
How do you identify those ALHIV who are at high risk of not linking to care? (Phase 1) What
strategies are effective in addressing barriers to linking to care? (Phase 2)
Do adolescents who self-test, including members of key populations, get linked to care
and if so, how?
What are effective testing strategies and their costs in identifying ALHIV in low prevalence
versus high prevalence contexts?
How do you create an environment that supports adolescents to test? What are best
practices for consenting adolescents for HIV testing?
What are the right messages/tools/apps to get high-risk adolescents to test, and those
testing positive, to link to care?
Retention in HIV care
Can providers’ enhanced capacity to deliver adolescent services improve retention?
What peer intervention models are effective in improving retention?
What is an appropriate differentiated care model for adolescents?
What are the effects of test and start on retention?
What is the effect of incentives (provider, client, and/or both) on retention?
Adherence to ART
How can we best identify ALHIV in need of adherence interventions before treatment
failure occurs?
What modalities of treatment simplification (regimen and delivery) can improve adherence
among adolescents?
What mental health interventions (targeting depression, anxiety, PTSD, ADHD) in the
context of adolescent HIV services can improve adherence?
How can mHealth and social network interventions effectively support adherence in
adolescents?
Can essential components of treatment literacy training/assessment and autonomy
development be effectively standardized using technological solutions?
How do we scale-up existing successful social support and resilience-enhancing models?
Transitioning to self-management/adult care
What are the key predictors of a successful transition for adolescents who are in HIV care?
What are existing models of delivery of care that facilitate transition for ALHIV?
Can providers monitor adolescents on modified adult care schedules (e.g., align with their
educational/school schedules)?
Can schools provide a platform to help ALHIV transition to self-care? Are there existing
models for strengthening school-based health services to support ALHIV in transitioning?
What are the comparative effects of the different transition models identified in question
2 on the outcomes below? HIV-related outcomes: viral suppression; adherence; retention
in adult care; disclosure of HIV status to the adolescent. Non HIV (well-being outcomes):
quality of life; future orientation; life skills; autonomy; mental health; economic stability.
Can we use m-health technology to achieve a successful transition?

Voting
results
Tied for
1st
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2nd
3rd
4th
5th
6th

1st
2nd
3rd
4th
5th
1st
2nd
3rd
4th
5th
6th
1st
2nd
3rd
4th
5th

6th

FINAL PERSPECTIVES
After identifying the priority research questions, the youth panelists shared their final reflections
about the meeting. Their inputs reinforced the value of youth participation in developing both
research and programs. It also reinforced the need to ensure that youth and researchers/
programmers/ donors speak the same language. For example, one of the research questions
identified as high priority was “to test a peer navigator model to improve linkages to care.” One
youth asked what peer navigators were only to realize that he himself was a peer navigator at a
youth development program but had never heard the term before. Another youth related that in
one of the working groups, she and her peers were asked how they would define transition in the
context of transitioning to self-management and adult care. The youth used analogies such as
transitioning to a new level in school to talk about the movement from one point in life to another.
But they also emphasized that for them and their peers, “transitioning” goes beyond HIV care
management to include building life skills and strengthening resiliency necessary for adulthood.
In conclusion, the meeting succeeded in defining a research agenda for improving HIV care
continuum outcomes among ALHIV for the larger HIV community as well as Project SOAR to
consider addressing as part of new or ongoing studies. To continue the momentum established
at the meeting, the research questions and the findings from the literature review will be shared
with participants attending the satellite meeting, “Listen Up: What Youth Living with HIV Need to
Achieve 90–90–90,” being held as part of the 2016 International AIDS Conference in Durban,
South Africa.

Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA ■ 11

12 ■ Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA

Appendix 1
Literature Review

Developing an Implementation
Science Research Agenda to
Improve the Treatment and
Care Outcomes among
Adolescents Living with HIV in
Sub-Saharan Africa

Prepared for
Project SOAR’s Technical Advisory Network Meeting
18–19 February 2016

Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA ■ A-1

Table of Contents
Introduction.................................................................................................................A-3
Methods.......................................................................................................................A-3
Results.........................................................................................................................A-5
Epidemiology of HIV among adolescents in sub-Saharan Africa............................. A-5
Adolescents who are members of key populations.................................................. A-5
HIV testing and counseling........................................................................................ A-6
Linkages to care......................................................................................................... A-8
Retention..................................................................................................................... A-9
Adherence to ART and achieving viral load suppression.......................................A-14
Transition to self-management and adult care......................................................A-20
Conclusion................................................................................................................ A-22

A-2 ■ Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA

INTRODUCTION
Significant advances have occurred in the field of HIV prevention, treatment, and care in recent
years. However, progress for the estimated 2.1 million adolescents living with HIV (ALHIV) has
been less than optimal (UNAIDS 2014; UNAIDS and WHO 2013). AIDS is currently the leading
cause of death among adolescents in sub-Saharan Africa (SSA) and the second leading cause of
death globally (Dick and Ferguson 2015). AIDS-related deaths are declining in every age group
except 10–19 years old. Additionally, only one in four children under the age of 15 has access to
antiretroviral therapy (ART) (UNAIDS 2013). Several new initiatives have recently been formed to
respond to this crisis including the “All In” initiative led by UNAIDS, UNICEF, and partners such as
United States Emergency Plan for AIDS Relief (PEPFAR). As both more attention and resources are
focused on adolescents globally, particularly ALHIV, it is critical that a strategic implementation
science research agenda parallels these efforts. Project SOAR, a United States Agency for
International Development (USAID)-supported global operations research project, implemented
by a multi-partner consortium of expert institutions, is in a unique place to bring together leaders
in the field to strategize and recommend priority implementation research questions, which if
answered, will improve HIV outcomes along the care continuum for adolescents.
This literature review serves several purposes. The paper examines and summarizes the existing
data on what we know about ALHIV along the care continuum, which encompasses:
• Identifying ALHIV through testing.
• Linking ALHIV to HIV care.
• Retaining ALHIV in care.
• ALHIV adhering to ART and achieving viral load suppression.
• ALHIV transitioning to adult care and self-management.
The paper also presents our knowledge to date regarding the service delivery successes and
challenges in engaging and supporting ALHIV to achieve these care continuum outcomes.
Finally, the paper served as a resource for Project SOAR’s Technical Advisory Network meeting
held 18–19 February 2016. This meeting aimed to identify the priority implementation science
research questions to improve HIV services, program approaches, and outcomes for this
vulnerable population.

METHODS
We conducted an initial review of the published literature by searching PubMed using terms such
as HIV, adolescent, Africa, and adherence. Abstracts were reviewed and articles pulled to assess
if they met the eligibility criteria including having data on a HIV continuum of care outcomes and
the study sample was from SSA and had a mean or median age between ages 10 and 19 years.
Given the existing systematic reviews and meta-analyses on the care continuum (e.g., there are
systematic reviews on adherence among adolescents and children), we searched PubMed for
new articles published between 1 January 2014 to 10 March 2016 to capture new manuscripts
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published after these previous review’s inclusion dates. The grey literature was not systematically
searched, however, reports and guidance were pulled from sources such as AIDSSTAR and the
websites of USAID’s implementing partners.
FIGURE 1 Disposition of citations during the PubMed search and screening process
Records identified through
PubMed search (N = 422)

Records published between
2014–2016 and screened
(n = 141)

Records excluded (n = 121)
Ineligible ages of study
participants (n = 80)
Qualitative studies (n = 18)
Not about ALHIV (n = 16)
Think pieces (n = 5)

Full-text articles assessed for
eligibility (n = 20)

Studies included from the
PubMed search (n = 20, 1 report
contributes to both adherence/
retention)
2—Testing/linkages
4—Retention
15—Adherence/VL suppression
0—Transitioning care

Not available on line/retracted
(n = 2)

Additional records identified
through other sources (n = 6)
1—HIV testing and linkages and
retention grey literature report
4—HIV testing and linkages
5—Retention
1—Adherence

Total material included separate
from meta-analyses and review
articles
3—HIV testing and linkages
9—Retention
16—Adherence
0—Transition
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RESULTS
Epidemiology of HIV Among Adolescents in Sub-Saharan Africa
An estimated 85 percent of the 2.1 million
TABLE 1 50% of the world’s ALHIV live in
adolescents living with HIV reside in SSA with
six countries
about 1.3 million in East and Southern Africa and
Country
% of world’s ALHIV
390,000 in West and Central Africa (Idele et al.
South Africa
13
2014). Just six countries, five in SSA plus India,
Nigeria
10
account for half of the world’s ALHIV (Kasedde
Kenya
8
2015). There are two main modes of infection for
Mozambique
6
ALHIV in sub-Saharan Africa. Perinatally acquired
Tanzania
6
infection is when an adolescent acquired HIV as
India
6
an infant through their mother during pregnancy,
labor, delivery, or breastfeeding. The other main
mode of infection is sexually acquired HIV (consensual or nonconsensual). The other modes
of transmission fall under parenteral transmission, or non-sexual transmission, and include
injecting drug use, traditional practices (e.g., female genital mutilation, scarification) and medical
procedures (e.g., blood transfusions) (WHO 2013).
Among younger adolescents (age 10–14 years), prevalence among males and females is fairly
even across countries in SSA, likely reflecting that a majority of these infections were acquired
through mother to child transmission of HIV. In mid and late adolescence (age 15–19 years),
when sexual transmission of HIV becomes a predominant mode of acquisition in ALHIV, a very
significant gap between the sexes emerges, with females up to two to five times more likely to be
infected than their male peers (Idele et al. 2014). This age-gender gap reflects the feminization
of the epidemic and the biological, social and structural factors that increase the risk young
females face in acquiring HIV through sexual transmission (Dellar, Dlamini, and Abdool Karim
2015). Globally, an estimated 30 percent of new HIV infections in 2014 occurred among 15 to
24 year olds (UNAIDS 2015) with HIV becoming the leading cause of death among adolescents in
SSA (Dick and Ferguson 2015). Despite efforts to increase access to ART, the estimated numbers
of HIV-related deaths among ALHIV between 2005 to 2012 increased by 50 percent, while the
global number of deaths across all ages decreased by 30 percent (WHO 2013).

Adolescents Who are Members of Key Populations
The vulnerability of key populations of youth (e.g., men who have sex with men, people who
inject drug) is well established. The 2014 WHO guidelines on HIV among key populations
states how adolescents who are members of these groups are at even greater risk than their
adult counterparts for poorer health outcomes related to HIV, STIs, and reproductive health.
Despite this recognition of their vulnerabilities, little data on the epidemiology of adolescents
who may be members of key populations in SSA are available (Bekker, Johnson, Wallace, and
Hosek 2015). Moreover, we were unable to find anything in the published literature on HIV care
continuum outcomes among such adolescents in SSA. This absence of data highlights the need
for innovative research to reach and engage adolescents who are members of key populations in
SSA.
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HIV Testing and Counseling
HIV testing and counseling (HTC) is a critical entry point to care and treatment; however, only
an estimated 29 percent of females and 20 percent of males between 15 and 19 years of age
in Eastern and Southern Africa have ever taken an HIV test and know their HIV status (UNICEF
2013). In areas with generalized epidemics, the WHO recommends routine HIV screening of
adolescents (10–19 year olds) coupled with initiation of ART for any adolescent who tests positive
regardless of his/her CD4 cell count or disease stage (WHO 2015b). WHO and UNICEF also
recommend making HTC services adolescent friendly and engaging (UNICEF 2013; WHO 2015b).
Box 1 highlights the key findings from the published literature on HTC among ALHIV in SSA, while
the text provides a more detailed review of the published evidence found.

BOX 1
Key findings from published literature on HTC among ALHIV in SSA
• A systematic review of HIV testing among adolescents found 15 eligible studies with data
from SSA. These studies examined provider initiated, outreach, home-based, and family
centered HIV testing and counseling. Adolescent uptake was highest among home-based
testing (86–99 percent). Provider initiated testing and counseling identified the greatest
proportion of HIV-positive adolescents (6–23 percent) (Govindasamy et al. 2015).
• Three home-based testing studies that required parental/guardian consent for adolescents
to test experienced high levels of uptake (Govindasamy et al. 2015), while data were not
found regarding the potential impact of parental consent on adolescent access and uptake
of testing in clinic settings
• A study on HIV self-testing had high uptake (89–100 percent) among 16–19 year olds in
Malawi (Choko et al. 2015).
• We did not find any published literature on school-based testing among adolescents in SSA.

A recent systematic review of published data from SSA assessed the acceptability of HTC and
the success of different testing strategies in identifying children and ALHIV (Govindasamy et al.
2015). Out of a total of 21 studies included in the review, 15 studies had participants with a
median or mean age between 10 and 19 years, all of which were conducted in East and Southern
Africa. These 15 studies examined the uptake of testing and receipt of results among adolescents
offered provider initiated testing and counseling (PITC; n = 5, 3 in-patient settings, 2 outpatient
settings), outreach testing (mobile clinic or outreach at a central site, n = 5), home-based testing;
n = 4) and family-centered testing (testing the families of a person living with HIV; n = 1). Six of
the studies provided HIV testing in the context of sero-prevalence surveys.
This review found that the uptake of testing by adolescents varied widely for PITC (40.7–95.5
percent) and outreach (9.9–90.2 percent). For home-based testing the uptake ranged from 85.8–
99.4 percent. In the one study examining a family center approach, 99 percent of adolescents
offered testing accepted to take the test. Nine of the 15 studies reported adolescent uptake by
gender, with only one finding a significant difference with females more likely to accept routine
HIV testing in an out-patient setting in South Africa compared to males (Ramirez-Avila et al.
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2012). The family-centered study, all four home-based testing studies, and three of the outreach
studies found no difference by gender in testing uptake (the other studies did not present gender
disaggregated data).
The strategy that identified the greatest percent of ALHIV was PITC (ranging from 6.3 percent to
23 percent) supporting the recommendation of routine HIV screening in health facility settings
(WHO 2015b). The non-facility based strategies identified a smaller proportion of positive
adolescents (home-based HTC ranged from 0.5–3.2 percent, family-centered study had 1.6
percent, and outreach studies ranged from 0.3–2.1 percent). Similar findings were presented in
a more recently published study comparing mobile HTC with home-based HTC in rural Swaziland.
This study tested 245 adolescents through mobile HTC and 1,924 through home-based HTC, with
2 percent of adolescents reached through both approaches testing positive for HIV (Parker et al.
2015). While the overall percentage of positives identified through community-based strategies
may be relatively small, as discussed by Govindasamy et al. community-based approaches may
be more successful in diagnosing HIV infection earlier in adolescence, leading to better health
outcomes (Govindasamy et al. 2015).
One of the biggest challenges to providing HTC among adolescents discussed in this review
article, and in the literature in general, is age of consent. (Govindasamy et al. 2015). Requiring
parental or guardian consent is seen as a potential barrier to accessing testing, care, and
treatment in adolescence. Moreover, the process of obtaining consent can be unclear and pose a
challenge for health care providers (Govindasamy et al. 2015; Kranzer et al. 2014). Three of the
home-based HTC studies included in the systematic review required parental or guardian consent
for younger adolescents to participate yet still yielded high uptake (85.8–93.6 percent) (Angotti
et al. 2009; Dalal et al. 2013; Naik, Tabana, Doherty, Zembe, and Jackson 2012). In addition,
the one outreach study that also clearly called for parental or guardian consent also had a high
proportion accept to undergo testing (90.2 percent). Further detail on how parental/guardian
consent and adolescent assent was obtained within these testing campaigns would help our
understanding of how consent challenges may be successfully addressed to create a supportive
testing environment for adolescents. In addition, further investigation is needed on how parental
consent limits clinic-based HIV testing among adolescents and how providers address these
challenges in order to reach sexually active adolescents, particularly young girls (WHO 2013
Annex 15).
In sum, while uptake of HIV testing among adolescents was relatively high in this review article,
one of the limitations pointed out by the authors was that none of the studies assessed linkages
to HIV care for adolescents who tested positive (Govindasamy et al. 2015). A recent study on selftesting, however, examined both uptake and linkages to care in Malawi (Choko et al. 2015). This
study defined HIV self-testing as “an individual performing and interpreting his/her own HIV test”
(page 2). This prospective randomized controlled trial enrolled participants age 16 and older.
One of the key findings was that adolescents were more likely to undergo self-testing in the first
year than adults (uptake was 89.3 percent of adolescent males and 100 percent of adolescent
female, a percentage that drops significantly among the older age groups). The percent who
tested positive also ranged from 1.1 percent among adolescent males to 3.5 percent among
adolescent females. The estimated linkage to care was 56.3 percent, although this data was not
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disaggregated by age. The authors did disaggregate though, data on coercion and found that
3 percent of 16–19 year olds reported being coerced into testing and that this percent did not
significantly differ from the adults in the study. There were no reported cases of intimate partner
violence or suicide related to testing during the first year of follow-up (Choko et al. 2015).
Data on other modes of HTC among adolescents in SSA, such as school-based testing, were
not found in the published literature (one article by Bandason et al. that is also included in the
Govindasamy review, explores HTC among primary school children; however the median age of
study participants was nine years) (Bandason et al. 2013). Cross-sectional data, however, among
secondary school students reveal low HIV testing uptake among students in general. Among
400 students in Arusha City, Tanzania, 29.3 percent have undergone HIV voluntary counseling
and testing (VCT) and received their results, with students aged 13 to 18 significantly less likely
than 19–24 year olds to test (aOR 0.37; 95 % CI 0.19–0.71), and males less likely to test than
females (aOR 0.29; 95 % CI 0.17–0.50)(Sanga, Kapanda, Msuya, and Mwangi 2015). Another
cross-sectional study in Ethiopia found only 8.8 percent of 339 students 18–24 years of age had
undergone VCT (Sisay, Erku, Medhin, and Woldeyohannes 2014). Findings from Zambia echo
these trends; in a community-based survey of 550 adolescents between 16 and 19 years of age,
out-of-school youth were significantly more likely to have taken an HIV test compared to those
attending school (aOR 2.95; 95 % CI = 1.32–6.59). This study also found that participants who
had discussed with a family member whether or not to take an HIV test were more than three
times as likely to have tested than their peers who had never had such discussions (aOR 3.51;
95 % CI = 1.08–11.47) (Denison, McCauley, Lungu, and Sweat 2014). A recent study in South
Africa found that out of 2970 students between the ages of 14 and 27, 71.8 percent reported
being willing to have an HIV test at the school (Madiba and Mokgatle 2015). While these studies
indicate potential for school-based HIV testing, experts during the Project SOAR Technical
Advisory Network meeting debated the merits of testing in schools, particularly among younger
adolescents, compared to more targeted testing approaches as a way to reach adolescents who
are living with HIV.

Linkages to Care
At the end of 2012, an estimated half of adolescents in low- and middle-income countries who
were eligible for ART at that time (based on WHO 2010 guidelines) had been started on therapy
(Idele et al. 2014). Since then the WHO guidelines have changed, first raising the CD4 threshold
for ART initiation to 500 cells/µL in 2013 and then completely removing the CD4 eligibility
requirements in 2015. Both these actions increased the numbers of adolescents eligible for
ART who had not yet been initiated (Idele et al. 2014; WHO 2015b), highlighting the need for
effective mechanisms linking adolescents who test positive to immediate care and treatment. Box
2 highlights the key findings from the published literature on linking ALHIV in SSA, while the text
provides a more in-depth look at the evidence we found.
Very limited data are available on the process of linking adolescents who test positive to HIV
care and treatment. The available data tend to focus on ART initiation among adolescents once
enrolled in care. For example, The AIDS Support Organization (TASO) in Uganda implemented
a home-based HIV testing and counseling program from 2005–2011 and tested 22,089
adolescents, aged 10–19 years, of whom 461 were positive and 140 were enrolled in HIV care
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BOX 2
Key findings from published literature on linking ALHIV to care in SSA
• Among the adolescents who tested positive in studies in Uganda and South Africa, between
25 percent and 80 percent did not enroll in HIV care.
• There are a paucity of data on models or methods of linking ALHIV in SSA to HIV care and
treatment services
• Data are not yet available on linking adolescents to care that reflect the recently revised
WHO 2015 guidelines of immediate ART initiation.

at TASO (30.4 percent). Out of these 140 enrolled adolescents, 26 percent (n = 37) were eligible
for care, and 89 percent of these started ART (n = 33). Overall, the proportion of HIV-positive
adolescents enrolling in TASO care increased during the first four years of the home-based HIV
testing and counseling program (from 9 percent to 41 percent), but then dropped to 20 percent
by 2010 (Livingstone et al. 2014). Cohort data from Kenya, Tanzania, Mozambique, and Rwanda
found that youth (15–24 years) in HIV care were more likely to be female (85 percent vs. 65
percent) and referred to care from prevention of mother and child transmission (PMTCT) programs
than their adult counterparts age 25 and older (20 percent vs. 9 percent), highlighting the role of
PMTCT efforts to link female ALHIV to HIV care (Lamb et al. 2014).
In South Africa, out of 11,522 adolescents and young adults (15–24 years of age) seen in a
stand-alone clinic developed specifically to provide adolescents with HIV management services
in Soweto, 3.6 percent tested positive for HIV (N = 410) of whom only 109 had their CD4 cell
count assessed and only 12 were eligible for treatment (Nkala et al. 2015). Moreover, around
25 percent of the youth who tested positive did not return to enroll in care or have a CD4 cell
test conducted (Nkala et al. 2015). These studies did not systematically assess the reasons
adolescents chose to link or not link with HIV care. Overall data on linking ALHIV to care in SSA
are sparse.

Retention
The following section examines retention to care among adolescents once enrolled in HIV care but
prior to initiating ART, known as pre-ART retention, followed by an examination of the literature on
retention once on ART.
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Pre-ART retention
BOX 3
Key findings from published literature on pre-ART retention for ALHIV in SSA
• Two studies examined pre-ART initiation retention (Koech et al. 2014; Lamb et al. 2014). An
estimated 19 percent of 10–14 year olds and an estimated 44 percent of 15–19 year olds
(and 49 percent of 15–24 year olds) were lost to follow up (LTFU) 12 months after enrolling
in HIV care, indicating a higher LTFU among older vs. younger adolescents.
• 15–24 year olds entering care through PITC, PMTCT and HIV/TB services experienced
greater pre-ART attrition than peers enrolled following VCT.
• Only one study examined program factors related to pre-ART retention and found no
evidence that offering adolescent-specific clinic hours, peer educators, or support groups
decreased the risk of attrition.

Levels of pre-ART retention
A 2015 systematic review (MacPherson et al. 2015) found only one article on ART retention
among adolescents in SSA (Lamb et al. 2014). This study analyzed routine clinic data from
312,335 patients enrolled in care between 2005–2010 in 160 clinics in Kenya, Mozambique,
Tanzania, and Rwanda (Lamb et al. 2014). This study categorized age into four groups: 10–14
years (young adolescents), 15–24 years (youth), 25–54 years, and 55 and over. One year
after joining care, but before initiating ART, 49 percent of the youth and 20 percent of the
young adolescents experienced attrition defined as lost to follow-up or known death, with LTFU
accounting for 98 percent and 87 percent of attrition respectively. The adjusted hazard ratio
(aHR) for attrition, compared to the reference population of 25–54 year olds was 1.50 (95 % CI
1.45–1.54) for youth; and 0.71 (95 % CI 0.64–0.79) for the young adolescents. When compared
directly, youth were at greater risk of attrition compared to the young adolescents (sHR = 2.11, 95
% CI 1.88–2.37).
Another study identified through the PubMed search assessed data from 22,832 patients, aged
10–24 years, enrolled in care between 2006 and 2011 in 109 clinics in Kenya (Koech et al.
2014). This study found that at 12 months 19 percent (95% CI 17.5–20.5) of the 10–14 year olds
were lost to follow-up (LTFU); not including death or transfer) compared to 44 percent (95% CI
42.6–46.0) of the 15–19 year olds and 44 percent (95% CI 43.4–45.1) of the 20–24 year olds.
Similar results were found at 24 months with an estimated 22 percent of the 10–14 year olds
compared to 50 percent of the 15–19 and 20–24 year olds being LTFU. Mortality did not differ by
age at either 12 or 24 months.
Factors related to pre-ART retention
The Lamb et al. study also examined the factors related to pre-ART attrition at 12 months
specifically for youth (15–24 year olds) (Lamb et al. 2014). In an adjusted analysis, youth across
four countries who entered HIV care from PMTCT, PITC, TB/HIV clinics, and unknown sources
were more likely to experience attrition than youth who enrolled following voluntary counseling
and testing (VCT). Non-pregnant females were also less likely to experience attrition than males
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(0.90, 95% CI 0.86–0.94) while no difference in attrition was found between males and pregnant
females. Youth with CD4 counts between 100 and 200 cells/µL were also significantly less likely
to experience attrition compared to youth with who had missing CD4 counts or CD4 results that
were less than 100 cells/µL or greater than 200 cells/µL. Finally, youth from Kenya, Mozambique
and Tanzania had greater risk of attrition compared to their counterparts in Rwanda.
Interventions to improve pre-ART retention
Overall there is limited evidence regarding interventions to improve pre-ART retention among
ALHIV in SSA. The Lamb article was the only published article that examined the relationship
between interventions and pre-ART retention among adolescents in sub-Saharan Africa. This
study found no evidence that offering adolescent-specific clinic hours, peer educators or support
groups decreased the risk of attrition among youth. The authors hypothesize that in the pre-ART
phase youth are lost soon after enrollment so they do not have time to engage in or benefit from
these types of services (Lamb et al. 2014).

Post-ART retention
BOX 4
Key findings from published literature on post-ART retention among ALHIV in
SSA
• Older adolescents (age 15–19 years) have higher estimates of LTFU after ART initiation
compared to younger adolescents (age 10–14 years) and children.
• Seven studies presented data on post-ART initiation attrition, with LTFU among 10–19 year
olds ranging from 4 percent to 20 percent at 12 months and 17 percent to 30.3 percent
at 24 months. Estimated LTFU rates per 100 person years ranged from 4.2 among 10–14
year olds to 23 among 15–19 year olds. Limited data exists on reasons why loss to followup occurs.
• 15–24 year olds entering care through PITC, PMTCT and HIV/TB experience greater postART attrition than peers enrolled following VCT.
• Two studies with older adolescents and youth examined youth friendly services. One study
found no relationship between youth services and retention (Teasdale et al. 2015). The
other study found that 15–24 year olds attending clinics that provide condoms experienced
significantly lower post-ART attrition (Lamb et al. 2014).
• In Uganda, adolescents (age 10–19 years) who refilled their ART at health facilities were at
greater risk for attrition at 12, 24 and 36 months, compared to peers who refilled their ART
at community drug distribution points (Livingstone et al. 2014).

Eleven studies (10 published and 1 report) present data specifically on retention to care after
ART initiation among ALHIV in SSA. These cohort studies analyzed routine clinic data collected
either prospectively or retrospectively and give insight into retention among adolescents after they
initiate ART (Bakanda et al. 2011; Berheto, Haile, and Mohammed 2014; Bygrave et al. 2012;
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Evans et al. 2013; Koech et al. 2014; Lamb et al. 2014; Livingstone et al. 2014; NabukeeraBarungi et al. 2015; Nglazi et al. 2012; Teasdale et al. 2015).
Loss to follow up
In a study of 10–24 year olds from 109 clinics in Kenya (described above), 8,016 youth had
initiated ART (Koech et al. 2014). The young adolescents (10–14 years) had lower levels of
LTFU: 10 percent (95% CI: 8.7–11.5) at 12 months and 18.5 percent (95 % CI 16.6–20.6) at 24
months compared to 15–19 year olds with 19.8 percent (95 % CI 17.7–22.2) LTFU at 12 months
and 30.3 percent (95% CI 27.7–33.2) at 24 months (Koech et al. 2014). Similarly in the Lamb
study, among the 140,798 patients who started ART and had 1 year of potential follow-up, 27.2
percent of the 15–24 year olds were LTFU (defined as documented death or LTFU) compared to
9 percent of the 10–14 year olds (HR 2.45, 95% CI 2.15–2.80). Loss to follow-up, rather than
death, accounted for the majority (>95 percent) of this post- ART initiation attrition for both youth
and young adolescents (Lamb et al. 2014).
Data from a cohort of 898 patients who initiated ART between 2005 and 2008 in rural Zimbabwe
also found that older adolescents experienced greater LTFU compared to younger adolescents,
with a rate per 100 person years of 4.2 (95% CI 2.5–7.0) among 10–14 year olds and 10.9
(95% CI 6.2–19.1) among 15–19 year olds (aHR 2.54, 95% CI 1.17–5.49) (Bygrave et al. 2012).
Similar data emerged from a retrospective analysis of data from seven clinics across urban
Gauteng and rural Mpumalanga in South Africa, with LTFU rates per 100 person years lowest
among young adolescents 10–14 years at 6.1 and highest among older adolescents 15 to 19
years at 23.3. Compared to adults over 25 years old, older adolescents were almost twice as
likely to be LTFU (HR 1.78, 95% CI 1.34–2.36), while young adolescents had less risk (HR 0.43
95% CI 0.26–0.69) (Evans et al. 2013). A retrospective chart review among 2,133 Ethiopian
patients revealed that the 74 adolescents (aged 11–19 years) were more than twice as likely to
be LTFU when compared to the 128 children who were less than 10 years of age (HR 2.1, 95%
CI 1.3–3.4) (Berheto et al. 2014). Both Evans (2013) and Berheto (2014) discuss how older
adolescents may not have the same level of caregiver involvement as younger adolescents and
children, potentially leading to these differences in LTFU by age.
Data from Uganda shows much higher retention proportions for adolescents. Among a cohort of
156 adolescents who had started ART in 2012 and were sampled from 10 districts in Uganda,
90 percent were still in care one year later (Nabukeera-Barungi et al. 2015). A cohort study
conducted among 617 HIV-positive adolescents (10–19 years) enrolled between January 2006
and December 2011 in TASO’s ART clinics in Uganda also generated high retention proportions
for adolescents: 96 percent at 12 months, 83 percent at 24 months, 76 percent at 36 months
and 71 percent at 48 months (Livingstone et al. 2014). The authors state these proportions
were similar when compared to adult patients who were age 20 years and older. This study also
explored differences among various cohorts of adolescents based on when they started ART,
with virtually no change existing in the first 6 months in the ART program with retention ranging
from 93 percent in the 2010 cohort to 100 percent in the 2006 cohort. However, there were
greater variations as more time passed with earlier cohorts from 2006 to 2009 having over 90
percent retention at 12 months compared to the 2010 cohort that had 79 percent retention at 12
months. This study also found that older adolescents, 15–19 years, were significantly more likely
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to experience non-retention during the first two years after ART initiation than younger 10–14 year
olds: aHR 1.88 (95 % CI 1.01–3.48) at 12 months and aHR 1.30 (95% 1.02–1.66) at 24 months,
a trend that becomes non-significant by 36 months.
Some studies, however, did not find significant differences in LTFU by age, including an earlier
study of 23,267 TASO patients who initiated ART between 2004 and 2009 (Bakanda et al. 2011)
and a study in Kenya with 924 patients comparing LTFU among those under 20 to those 20 years
and older (Ojwang et al. 2015). Similarly, data from among 883 patients enrolled in a prospective
cohort study in a public sector community-based ART program in Cape Town South Africa also
found no significant difference in LTFU or mortality between age groups comparing 9–19 year
olds to 20–28 year olds. This study did find, however an increased risk in virological failure (aHR
2.06, 95% CI 1.11–3.81) in adolescents compared to adults (Nglazi et al. 2012).
Post-ART initiation LTFU due to mortality among ALHIV
While LTFU was clearly higher among older adolescents compared to younger adolescents, data
from four studies showed no significant differences in mortality by age (Bakanda et al. 2011;
Evans et al. 2013; Koech et al. 2014; Nglazi et al. 2012). Data from a cohort of 898 patients who
initiated ART between 2005 and 2008 in rural Zimbabwe did find that young adolescents (10–14)
had the lowest rate of death per 100 person years compared to adolescents (15–19 years) and
young adults (19.1–24 years): 3.6 (95% CI 2.0–6.3); 5.4 (95% CI 2.4–12.1); and 6.6 (95 % CI
3.7–11.9) respectively (Bygrave et al. 2012).
Factors related to post-ART retention
Among 10–19 year olds attending TASO clinics in Uganda, factors related to non-retention at 12
months included having a WHO stage 3 or 4 at ART initiation (aHR 2.21, 95% CI 1.19–4.09), a
variable that was no longer significant at 24 or 36 months. On the other hand, having a pre-ART
CD4 cell count of >100 cells/µL was not significantly related with attrition at baseline, but was at
24 and 36 months. This analysis also found no differences between the sexes in terms of LTFU
at 12 months, but with time females had significantly less risk of being LTFU compared to males:
aHR 0.68, 95% CI 0.52–0.88 at 24 months and aHR 0.79, 95% CI 0.64–0.98 at 36 months. In
the multi-country study by Lamb et al. (2014) an analysis specifically on 15–24-year-old youth
found that male youth had greater attrition than female youth and, similar to pre-ART loss to
follow up, patients entering care through PITC or unknown points of entry had greater attrition
rates than youth entering through VCT. This analysis also found less attrition among youth with
a CD4 count of 100–200 cells/µL when compared to either counts that were higher than 200
cells/µL or lower than 100 cells/µL at ART initiation, and that youth attending clinics in Kenya,
Mozambique and Tanzania had higher rates of post-ART attrition compared to youth attending
clinics in Rwanda.
Interventions to improve post ART initiation retention
Only one study provides information solely on adolescents that examines retention by specific
program strategies. In Uganda, adolescents who refilled their ART at health facilities were
consistently at greater risk for attrition compared to their peers refilling at community drug
distribution points: aHR 2.58 (95% CI 1.26–5.29) at 12 months; aHR 1.59 (95% CI 1.23–2.05) at
24 months and aHR 1.3 (95% CI 1.05–1.61) at 36 months (Livingstone et al. 2014).
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Two other studies examined how different program strategies may relate to adherence among
young adults. For example, 15–24 year olds in Lamb’s multi-country study had significantly lower
post-ART attrition if they attended clinics that provide condoms versus their peers who attended
clinics that did not provide condoms (RR = 0.47, 95% CI 0.32–0.70) (Lamb et al. 2014). This
study found no evidence of differences in attrition when other youth friendly services were offered
in addition to regular services, including adolescent specific clinic hours, screening for STI’s and
the provision of hormonal contraceptives. In a study in Kenya of 10–24 year olds (median age
21 years, IQR 19–23) the authors found no difference in attrition at a six month follow up among
youth attending clinics with youth friendly services compared to peers attending clinics without
youth friendly services (Teasdale et al. 2015).

Adherence to ART and Achieving Viral Load Suppression
BOX 5
Key findings from published literature on adherence to ART and achieving viral
load suppression among ALHIV in SSA
• Estimates of ART adherence among adolescents in SSA vary greatly from 16 percent to 94
percent based on the age of the study participants, the way adherence was measured, and
the time frame covered.
• Five systematic reviews identified data from 20 unique published studies containing data
on adolescents living with HIV in SSA. Out of these 20 articles, only 8 reported exclusively
on adolescents, with the rest combining data from adolescents with data from children
and/or young adults.
• Studies examining factors related to adherence among adolescents in SSA tend to have
cross sectional study designs and often smaller sample sizes.
• Three studies that disaggregated adherence data by age found that adolescents were more
likely to have incomplete adherence and viral load failure compared to young adults and
adults.
• The factors related to adherence among adolescents (gender, disclosure, family factors,
and medical/health factors) varies depending on whether the sample is combined with
children or focused on adolescents only, and if the measure of adherence is a caregiver
report versus other measures of adherence (e.g., self-report, pill counts).
• Few published articles examine the impact of interventions on adherence among
adolescents and those that do provide preliminary data on the positive impact of group
sessions on adolescents’ adherence behaviors.

Levels of adherence
Several systematic reviews and a meta-analyses have assessed ART adherence among
adolescents and children, both globally and specifically in middle and low income countries,
producing adherence estimates ranging from 16–94 percent (Hudelson and Cluver 2015; Kim et
al. 2014; Vreeman et al. 2008). However critical questions remain regarding how well the existing
literature provides insight and evidence regarding the adherence behaviors of ALHIV in SSA.
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In the first review by Vreeman et al. published in 2008, only six out of the 17 studies that met
the eligibility criteria were from SSA, and out of those only two had participants with a median
age that fell within 10 to 19 years. In one of these studies, conducted among 170 HIV-infected
children between the ages of 2 and 18 years in Uganda, caregivers estimated that 89.4 percent
of participants achieved >95 percent adherence based on a three-day self-report, a percentage
that increased to 94.1 percent with clinic based pill counts and dropped to 72 percent during a
home-based unannounced pill count a few weeks later (Nabukeera-Barungi, et al.,2007). In the
other study, in–depth interviews were conducted with 42 Uganda children and their caregivers
jointly, with 29 percent of these pairs reporting excellent adherence (never missed any dose, with
the time frame not specified (Bikaako-Kajura et al. 2006). Adherence in both articles was not
disaggregated further by age.
Kim et al. published the next review in 2014 with data from 50 eligible studies that assessed ART
adherence among adolescents and young adults living with HIV globally. Eight of these studies
were conducted in sub-Saharan Africa and produced a pooled adherence estimate of 83.8
percent [95% CI 78.9–88], a percentage that is much higher when compared to the overall global
estimate of 62.3 percent [57.1–67.6]. Unlike the measures used in the articles in the Vreeman
systematic review, six of the SSA articles in the Kim meta-analysis used viral load test results to
assess adherence, and one article had data from pill counts (Nabukeera-Barungi et al. 2007),
one used pharmacy refill data (Nachega et al. 2009), and one used self-reports (Wiens et al.
2012). Four of the studies contributing to the largest samples sizes for the SSA meta-analysis
adherence estimate, however, included young adults up to age 24 (Evans et al. 2013; Mutevedzi
et al. 2011; van Cutsem et al. 2010) and age 28 (Nglazi et al. 2012). In two of these articles the
authors disaggregated the data by age. In one study they found that young adolescents (10–14)
had higher virologic failure rates (6.3 per 100 person years) compared to older adolescents (3.8
per 100 person years) and that younger adolescents (10–14) (HR 2.94 95% CI 1.63–5.31),
older adolescents (15–19) (HR 2.90 95% CI 1.74–4.86) and young adults (20–24) (HR 1.53
95% CI 1.13–2.08) all had greater risk of viral failure when compared to adults 25 years and
older (Evans 2013). Another study found that adolescents (ages 9–19) had a greater risk of
viral failure compared to young adults (ages 20–28) (aHR 2.06, 95% CI 1.11–3.81) (Nglazi et al.
2012). Nachega et al. also found that when compared to adults, 154 adolescents in South Africa
were less likely to achieve 100 percent adherence measured through pharmacy refill data (20.7
percent vs. 40.5 percent at 6 months; 6.6 percent versus 20.6 percent at 24 months).
A more recent systematic review on adherence was published in 2015 by Hudelson and Cluver.
The purpose of this review of adolescents living with HIV in low- and middle-income countries was
to identify the factors related to adherence. Out of 15 eligible studies, 9 were conducted in SSA
and only one overlapped with the articles in the earlier reviews (Nabukeera-Barungi et al. 2007).
While all studies had at least 50 percent of participants who were between 10 and 19 years, the
age ranges across articles encompassed 6 months to 21 years. In addition, all the studies used
cross sectional designs, and all but one used a 95 percent cutoff for good adherence based
on caregiver and self-reports and pill count (Kikuchi et al. 2012, used a cutoff of 85 percent).
Only one study assessed adherence by viral load (Lowenthal et al. 2012). Adherence estimates
across these studies ranged from a low of 16 percent based on monthly self-report among 229
participants in Zimbabwe (Mavhu et al. 2013) to a high of 94 percent using clinic-based pill count
among 170 participants in Uganda (Nabukeera-Barungi et al. 2007).
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A separate meta-analysis article, published in 2016, examined viral suppression among
adolescents on ART (Ferrand et al. 2016). This review identified seven articles from SSA, five
of which have appeared in earlier adherence reviews. The proportion of adolescents achieving
viral suppression varied greatly, ranging from 27 percent to 89 percent at 12 months, 44
percent to 87 percent at 24 months and two studies reported an overall proportion with
virological suppression at 61–62 percent. Sample sizes for these studies ranged from 65 to
652 participants. Another study examining routine viral load monitoring in Swaziland found 48
percent of 277 adolescents were never linked to their viral load (VL) test result or underwent VL
testing. Out of the adolescents who underwent VL testing, 30 had a detectable viral load of whom
14 had confirmed virologic failure (Jobanputra et al. 2014). In another analysis of the Swaziland
data, the authors found adolescents (n = 588) were significantly more likely to have a detectable
viral load than adults (aOR 3.2, 95 % CI 2.2–4.8) and significantly less likely to re-suppress after
adherence counseling compared to adults (aOR 0.3, 95% CI 0.2–0.8) (Jobanputra et al. 2015).
In Khayelitsha, South Africa, among 118 study participants from two primary care clinics (median
age 10, IQR 5–14), 33 percent were failing their ART and had not achieved viral suppression
(Bernheimer et al. 2015). A study among 161 adolescents and children in Tanzania compared
VL test results from 2008–2009 to a second set of results from 2012–13. Sixty percent (44/65)
of the participants who were 12 or older during the study remained on first line regimens and
virally suppressed compared to 95 percent of those who were younger than 12 years during the
assessments. Overall the authors found a significant and large (3.3 fold) increase in the odds
of virologic failure among adolescents, and an even greater odds of virologic failure (8.8, CI not
reported, p < 0.01) for participants who remained in adolescence during the study (Dow et al.
2014).

Factors related to adherence and viral suppression
Out of the literature found, 20 studies (9 identified by Hudelson and Cluver 2015, 10 identified
through PubMed, and 1 found in the grey literature) examined factors associated with adherence
to ART among ALHIV. Adolescents comprised at least 50 percent of the study populations in
these articles, with 5 articles exclusively enrolling adolescents between the ages of 10 and 19
years old. Around half of these articles assessed the factors associated with adherence while half
assessed non-adherence as their primary outcome. These studies in general were cross-sectional
with relatively small sample sizes (ranging from 82 up to 1,000 participants) producing mixed
results. The key findings from these articles are grouped by theme/factors below.
Gender
Four studies had adherence data disaggregated by sex. Two studies found that males were more
adherent than females. In Uganda, data from 948 children and young adolescents between 3
and 15 years of age found that males were more likely than females to have 95 percent or more
adherence using a three day self-report measure that was completed by the child or caregiver
[crude OR 1.9, 95% CI 1.2–3.1] (Musiime et al. 2012). In Tanzania, a study among 183 HIVinfected children and adolescents between the ages of 2 and 17 years found that males were
more than twice as likely to have good adherence across three measures: pill count, 2 day
measure and a 30 day measure [OR 2.55, 95% CI 1.05–4.87] (Nsheha et al. 2014).

A-16 ■ Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA

The opposite, however, was found in a study in Botswana conducted among only 13–18 year
olds (n = 82). This study found that males were significantly more likely to have suboptimal
adherence compared to females when assessing pill count data over the past month [OR 3.29,
CI 1.13–9.54] (Ndiaye et al. 2013). Data from 285 adolescents aged 15 to 19 in Zambia also
found that males had greater odds of missing two consecutive days of ART in the past 3 months
than females [aOR 1.92, 95% CI 1.05–3.54], while there was no difference between males and
females in terms of having less than 90 percent of their 6 month pharmacy refill pills (Denison
2015 unpublished).
Disclosure
Six published quantitative studies have examined the relationship between adherence and
the adolescent’s knowledge of his/her HIV seropositive status. Three studies from Ethiopia, all
conducted among young adolescents combined with children, found that participants who were
unaware of their HIV status were significantly more likely to adhere to ART. Two of the studies
assessed adherence using unannounced home-based pill counts one week after the clinic visit [n
= 210, aOR = 2.35, 95 CI 1.09–5.06] (Biressaw et al. 2013) and the other used caregiver 7-day
adherence reports [n = 390 OR 2.53, 95% CI 1.24–5.19] (Biadgilign et al. 2008). Another study
conducted in Ethiopia also used caregiver reports and found disclosure to a child significantly
related to a reduced odds of adherence [n = 342, aOR = 0.27, 95% CI:0.24–0.32) (Dachew,
Tesfahunegn, and Birhanu 2014).
These data are in stark contrast to findings from another study in Ethiopia (n = 464) which found
that participants who knew their status were more likely to have achieved adherence based on
caregiver reports of >95 percent adherence in the past month [aOR = 3.47 95% CI 2.10–6.81]
(Arage, Tessema, and Kassa 2014). Just one study, conducted in South Africa, enrolled only
adolescents and found that when participants knew their HIV-positive status they were more than
twice as likely to self-report higher adherence in the past week [OR 2.18, 95% CI 1.47–3.24]
(Cluver et al. 2015). Among those adolescents who were perinatally infected and learned their
HIV status prior to turning 12 years old, adherence was also significantly higher [OR 2.18, 95%
CI 1.47–3.24] compared to adolescents who learned their HIV status after turning 12 years
old (Cluver et al. 2015). A study in Uganda found no difference in adherence based on the
participant’s knowledge of his/her serostatus [n = 170, CI 091, 95% CI 0.39–2.07] (NabukeeraBarungi et al. 2007).
Family and household factors
Several studies found family level factors related to ART adherence among adolescents. In
Botswana, Lowenthal et al. (2015) found that the odds of virologic failure at the 3-month clinic
visit was much greater among adolescents who did not have their parents or guardian attending
the clinic with them compared to those who did [n = 300, OR 4.5, 95% CI 1.5–4.1]. A similar
finding emerged from data from 262 adolescents in Zimbabwe with adolescents whose parents
were always in the room during clinic visits having greater self-reported adherence than those
without their parent or guardians present [OR 2.1, 95% CI 1.3–3.5] (Gross et al. 2015). Another
study conducted in Uganda found that when the only person who knew the child’s serostatus
was the primary caregiver, versus others also knowing the child’s serostatus, the odds of nonadherence was three times greater [OR 3.34, 95% CI 1.14–9.82] (Nabukeera-Barungi et al.
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2007). Young adolescents and children in Ethiopia who were not aware of their caregiver’s health
problem were also more adherent than their peers who were aware [OR = 2.45, 95% CI 1.25–
4.81)](n = 390) (Biadgilign et al. 2008).
Another study found that caregivers’ knowledge about ART [aOR 2.72, 95% CI 1.82–5.39] and
caregivers not currently using substances (i.e. alcohol, chat and/or cigarettes) [aOR 2.21, 95% CI
1.34–7.13] were related to caregivers’ reports of adherence in the past month among 440 young
adolescents and children in Ethiopia. This same study found that adolescents whose caregivers
had at least a secondary education compared to those who could not read or write were less
likely to be adherent [aOR 0.59. 95% CI 0.21–0.83] (Arage et al. 2014). Another study from
Ethiopia also found that caregivers’ knowledge about ART was significantly related to adherence
[aOR 4.7, 95% CI 3.7–5.6] (Dachew et al. 2014).
In Ethiopia, children and young adolescents were more likely to adhere if their caregiver
was married [aOR = 7.85 (95% CI: 2.11,29.13)] and widowed/divorced [aOR = 7.14 (95% CI:
2.00,25.46)] compared to single caregivers (Biressaw et al. 2013), while participants with
widowed caregivers in Uganda experienced worse adherence that those with married caregivers
(Musiime et al. 2012). In Rwanda, multivariate analysis revealed less adherence among
adolescents who were double orphaned compared to maternal, paternal or non-orphans (n = 717)
(Kikuchi et al. 2012). A study in South Africa did not find any evidence of a relationship between
adolescent adherence and if their caregiver was a biological parent or not (Cluver et al. 2015).
In two studies, the authors did not find evidence of a significant relationship between adherence
and several family level measures including family support, caregiver relations, and discussions
of adherence (n = 82) (Ndiaye et al. 2013) or orphan status, having an HIV-infected sibling, and
social support (Nabukeera-Barungi et al. 2007). In a study in Tanzania, children and adolescents
were more adherent if the caregivers could afford to bring the child to the clinic (OR = 3.4, CI
1.60–7.36), provide additional food (OR = 2.93, CI 1.23–6.90), and had a monthly household
income above 1000,000 Tanzanian shillings [OR = 0.44, CI 0.21–0.96] (Nsheha et al. 2014). In
Brazzaville, Congo, among 10–19 year olds, being younger and parents’ administration of ART
were both significantly associated with adherence (Mbika et al. 2014).
Medical- and health-related factors
There are mixed findings about the health of adolescents and children and subsequent
adherence. Hospitalization (OR 0.44 for non-adherence, 95% CI 0.20–0.92) (NabukeeraBarungi et al. 2007), and having a baseline WHO clinical stage III/IV [OR = 3.18, 95% CI: 1.21–
8.40] (Biressaw et al. 2013) were related to adherence in two studies. In other studies, worse
adherence and virologic failure were associated with side effects and symptoms (Nsheha et
al. 2014) and mental health measures (Dow et al. 2016; Lowenthal et al. 2012; Lowenthal et
al. 2015; Mavhu et al. 2013). One study also found that children on d4T/3Tc/EFV combination
ART were less likely to be adherent [OR = 0.10, 95% CI: 0.02–0.53] (Biressaw et al. 2013), and
another study among 1–18 year olds in Botswana found that adherence less than 95 percent, VL
failure (VL >400 copies/mL), and CD4 percentage less than 15 percent were all associated with
short stature (Joel et al. 2014).
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Another factor related to adherence included rural and urban residency. In one Ugandan study,
adolescents had greater odds of poorer adherence among 183 rural participants compared
to 1573 urban participants (aOR 2.64, 95% CI 1.28–5.43) (Nabukeera-Barungi et al. 2015).
Another study from Uganda, however, found no difference by rural/urban status in terms of selfreported adherence of greater than 95 percent (91.3 percent among rural participants vs. 88.2
percent urban participants, p = 0.131) but did find that rural adolescents were significantly more
likely to have pill counts of 95 percent or greater than urban adolescents (88.8 percent vs. 78.8
percent, OR 0.5, 95% CI 0.3–0.7). Adherence was also related to proximity to health care in
Ethiopia (Arage et al. 2014), and in Tanzania (Nsheha et al. 2014) with non-adherence related
to not attending the clinic regularly and having missed drug doses in the past six months. One
author also found that in Uganda parents not paying for treatment and having received nutritional
support were related to non-adherence, while taking co-trimoxazole medication/syrup increased
the odds of adherence [OR = 3.65 (95% CI 1.24, 10.74)](Biadgilign et al. 2008).

Interventions to improve adherence
Few published studies provide evidence regarding effective interventions to support ART
adherence specifically among adolescents in SSA. MacPherson’s 2015 review of the literature
from 2001–2014 on this topic resulted in only one published article (MacPherson et al. 2015).
This study piloted the “VUKA” program among 10–13 year olds living with HIV in South Africa
(Bhana et al. 2014). VUKA is the adapted version of the Collaborative HIV Prevention and
Adolescent Mental Health Family Program (CHAMP) that is a multi-session and family-based
intervention (Bhana et al. 2010; McKay et al. 2007). The intervention consisted of six group
sessions delivered over three months to 10–13 year olds living with HIV and their families. Based
on self-reported missed ART over the past six months, the VUKA intervention arm participants had
significantly greater improvements in their adherence scores than participants in the comparison
arm (VUKA = 1.10; Control = –0.43 at baseline and follow up, p < 0.05; n = 65).
In another review by Adejumo et al. identified through the PubMed search, the authors identified
six studies that described effective intervention programs to improve ART adherence (Adejumo et
al. 2015). Out of these six, only three focused on adolescents, including the VUKA study described
above, as well as a conference abstract presenting data on adolescent peer support groups
in Uganda (Musiime et al. 2007) and a psycho-social support group intervention in Zimbabwe
(Mavhu et al. 2013). The program in Uganda consisted of monthly meetings on Saturday that
included health education talks, indoor and outdoor games, art, crafts and music. This program
was led by counselors, nurses and doctors and involved adolescents and their caregivers. Out of
the 27 percent of the participants who were identified as having poorer adherence at baseline
(adherence measure not defined) all 16 achieved 95 percent or greater adherence within 3
months. The other study by Mavhu et al. (2013) found that the majority of the 229 interviewed
participants attended monthly psycho-social support groups for HIV-infected adolescents in
Zimbabwe and that 95 percent found the groups to be helpful. Based on the results of their
formative research, the authors propose an adolescent and family-based intervention consisting
of community adolescent treatment support, cognitive-behavioral therapy, and caregiver training
to enhance adolescent support (Mavhu et al. 2013).

Developing an IS research agenda to improve the treatment and care outcomes among ALHIV in SSA ■ A-19

Since these review articles, two other studies have been published providing data on program
effects on adolescent adherence. In Zimbabwe, data from 262 adolescents found that
participants who attended professionally run support groups had greater odds of achieving
excellent adherence compared with non-participants [OR 1.8, 95% CI 1.1–3.0] (Gross et al.
2015). A medical file review of 200 patients in Swaziland, however, found that enhanced
adherence counseling was not significantly associated with increased odds of viral suppression
(Jobanputra et al. 2015)

Transition to Self-management and Adult Care
As ALHIV transition into adulthood it is critical that they gain the skills to successfully manage
their HIV and their health. This process is unique for adolescents given the stages of development
they undergo and the many challenges they, their families, and health care providers face such
as cognitive and developmental delays, disorganized social environments (parental illness and
loss, school absences), health risk behaviors, and co-morbidities (Sawyer et al. 2007). To address
these issues and to maximize resilience among adolescents, the PEPFAR/USAID guidance on the
transition of care for ALHIV emphasizes several key issues: (1) for some adolescents this process
includes a physical transition from a pediatric or adolescent model of care to an adult facility;
(2) that many ALHIV in SSA already receive care in adult HIV clinics and while these adolescents
are not changing care providers or facilities, they still need support to develop the skills to
self-manage their HIV; and (3) this period of transition and concept of HIV self-management
is a complex and “multifaceted, active process that attends to the medical, psychosocial, and
educational or vocational needs of adolescents” (Duffy and Sharer 2014). In the PEPFAR/USAID
technical brief on transitioning ALHIV they further break down the factors that self-management
encompass and the support that ALHIV need into two specific categories: (1) individual growth
and environmental support, and (2) clinical support (Sharer and Fullem 2012). Examples of these
follow the key findings in Box 6.

BOX 6
Key findings from published literature on transitioning to self-management and
adult care among ALHIV in SSA
• The transition of ALHIV refers to not only the movement from a pediatric or adolescent
model to an adult model of HIV care, but also includes the development of selfmanagement skills as ALHIV grow into adulthood and assume responsibility for their HIV
care, regardless of where they receive treatment.
• While adolescent and pediatric services exist in SSA, many ALHIV already attend adult HIV
care as this is the only service available to them.
• The search did not find any published data on the effectiveness of a transition model or
approach among adolescents in SSA.
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Individual growth and environmental support
This aspect of self-management as presented in the technical brief consists of psychosocial
support (mental health, grief and bereavement), sexual and reproductive health, substance use,
and future planning. In a review article of adolescents living with chronic conditions, the authors
found emerging evidence that ALHIV are at least as likely, if not more likely, to engage in risk
behaviors such as drinking, drug use, and having sex, as their healthy peers (Sawyer et al. 2007).
Furthermore, 20 percent of women globally have had a child by age 18, a proportion that is much
higher in many SSA countries (UNICEF 2013). Overall there is a growing body of literature on the
sexual and reproductive health needs of ALHIV (Birungi 2011; Birungi et al. 2009a; Birungi et al.
2009b; Birungi et al. 2011; Obare and Birungi 2010; Obare, Birungi, and Kavuma 2011; Obare, van
der Kwaak, and Birungi 2012) and the importance of viewing adolescent health care from a human
rights perspective (Mburu et al. 2013)

Clinical support
This aspect of self-management consists of supporting adolescent self-care and their clinical
management of HIV and mental health issues (Sharer and Fullem 2012). Clinical needs may
vary between perinatally infected adolescents and their horizontally infected peers, with
adolescents infected since birth more likely to experience greater complications, side effects, and
developmental delays (Sharer and Fullem 2012). These differences may mean more perinatally
infected youth are receiving second line treatment and are at greater risk for drug failure and
resistance (Sharer and Fullem 2012). Co-morbidities (e.g., psychiatric illness) and emerging
health challenges (e.g., cardiovascular disease risk and bone health) also need to be considered
as adolescents transition into adult care (Lee and Hazra 2015). Evidence is mounting that
adolescent females have worse PMTCT outcomes when compared to adults (Fatti et al. 2015;
Horwood et al. 2013) and use maternal health care less frequently when pregnant (Birungi et al.
2011). A study conducted in South Africa also found that the most common reason for changing
an ART regimen among older adolescents was pregnancy, something the authors point out as
evidence indicating the need for contraceptive counseling and access to birth control among
ALHIV (Evans et al. 2013).
Overall, an integrated approach to transitioning ALHIV to self-manage their HIV is supported by
the literature specifically on ALHIV (Lee and Hazra 2015) as well as the literature on pediatric
chronic illness management more broadly (Modi et al. 2012). These models and guidance also
emphasize the important role that families have in supporting adolescents living with chronic
conditions, including HIV (Amzel et al. 2013; Rosen et al. 2003; Sawyer et al. 2007), especially
as the majority of the self-management behaviors ALHIV need to perform such as adherence,
HIV status disclosure, and safe sexual behaviors, occur in their homes and communities, not
in the clinic. This role of family is reflected in a definition of pediatric self-management as the
“interaction of health behaviors and related processes that patients and families engage in to
care for a chronic condition” (Modi et al. 2012). This role varies greatly with some caregivers
actively engaging in the care and treatment of ALHIV and others shifting treatment responsibility
to the ALHIV as they reach mid adolescence (Denison et al. 2015). Fears of stigma and disclosure
also often isolate adults and ALHIV from sources of family and community support and the
connection between adult caregivers of ALHIV and the clinic where ALHIV receive care is often
weak (Denison et al. 2015). Furthermore, there is evidence that managing a chronic illness
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can have a negative impact on caregivers and families, particularly in low-income and highly
stigmatized environments (Thurman, Jarabi, and Rice 2012). These issues reinforce the need to
“consider healthcare transition as a continuum and not separate, discrete moves from pediatric
to adolescent to adult clinic settings” (Lee and Hazra 2015).
While there is an international call to support HIV self-management among adolescents
(Chakraborty et al. 2013; Gilliam et al. 2011; WHO 2013), including adhering to ART, practicing
safer-sex behaviors, and transitioning to adult care (Pequegnat et al. 2001; Pequegnat and Bell
2011; Pequegnat and Szapocznik 2000; Perrino et al. 2000; Thurman et al. 2012), the reality
is that ALHIV in SSA often do not have access to adolescent-specific services or opportunities to
build life skills (WHO 2013).
Often the only program provided in response to the needs of adolescents in SSA are elements of
youth friendly services (e.g., special clinic hours) and the provision of clinic-based support groups
for ALHIV. However, such group programs are often vulnerable to changes in staff and funding
and are often not systematically incorporated into service provision. In the next section the data
available on transitioning adolescents to adult HIV care in SSA will be examined.

Transitioning to adult care
Several guidelines exist on transitioning adolescents from a pediatric or adolescent model of
care to an adult HIV care service (IAPAC 2015; Rosen et al. 2003; Sharer and Fullem 2012). Such
guidelines often emphasize a comprehensive approach to adolescent health care that engages
young people and transfers youth based on cognitive and emotional readiness rather than on
age alone. Despite this guidance, there is a paucity of data on the use of these guidelines and
their impact on the care continuum outcomes of transitioning ALHIV. A 2014 review article on
transitioning from pediatric to adult HIV care did not find a single article based in sub-Saharan
Article (Hussen et. al 2014). In the WHO testing guidelines for adolescents, data from a survey
conducted among 477 youth living with HIV (10–24 years of age) from 57 countries is presented.
While the majority of participants were enrolled in HIV care, only 282 were attending pediatric or
adolescent HIV care facilities. This reflects the reality that many adolescents often already attend
adult HIV clinics for their care. Out of those 282 in pediatric or adolescent settings, the following
percentages of youth have had discussions with their provider about transitioning to adult care:
38 percent had at least one discussion, 40 percent 2–3 discussions and 22 percent more than
three discussions (WHO 2013). No other data on models or outcomes related to transitioning
adolescents to adult HIV care in SSA were found.

CONCLUSION

This paper provides a summary of key findings related to the care continuum outcomes
among ALHIV in SSA. We have prepared the table below to highlight our main conclusions and
implications that emerged from the literature we reviewed according to the key care continuum
domains. The table also includes the number of studies found related to each of the domains.
As illustrated in Table 2, the published literature on the care continuum outcomes among ALHIV
in SSA is sparse, particularly age disaggregated data on linking positive youth to care and on
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TABLE 2 Summary of published literature on the care continuum outcomes among
ALHIV in SSA
Domain
# of studies
Main findings
Potential implications
HTC and
• 2 systematic
• Home-based testing had high
• Evaluate different
reviews with
uptake among adolescents
models of HTC to
linkages to
16 studies on
even when adult permission
reach adolescents and
care
adolescents.*
was required.
identify ALHIV earlier in
their infection.
• 3 studies (one a
• PITC yielded the largest
program report,
proportion of ALHIV.
• Examine ways to obtain
two published) with • None of the HTC studies
parental or adult
linkage to care
permission to test.
assessed linkages to care
data.
for adolescents who tested
• Identify linkage
positive.
mechanisms for
different HTC
• Significant percentage of
strategies given WHO
adolescents who tested
new guidelines on ART
positive do not enroll in HIV
initiation.
care.
Retention
• 1 systematic
• Older ALHIV (15–19) appear
• Disaggregate data by
review.
to have poorer retention rates
age to assess retention
compared
to
younger
ALHIV
among ALHIV in
• 9 additional studies
(10–14)
both
before
and
after
country programs.
identified through
ART
initiation.
PubMed and a
• Rigorously test
literature review.
• One study found less attrition
different models of
with ART refills at community
care in improving
drug distribution points vs.
retention among ALHIV.
health facilities.
• Other studies that combined
ALHIV with young adults
produced mixed findings on the
relationship between youthfriendly services and retention
in care.
Adherence
• 5 systematic
• Adherence estimates range
• Conduct intervention
reviews, data from
from 16–94 percent
studies to assess
20 unique studies. • Adherence studies often.
program impact on
adherence among
• 16 additional
combine ALHIV with children
ALHIV.
studies identified
and/or young adults.
through PubMed
• ALHIV adhere less than young
and the grey
adults in the few studies that
literature.
disaggregated the data.
• Few studies examined factors
related to adherence, with
preliminary data showing a
positive relationship with group
sessions.
Transition
• 1 systematic review • Many ALHIV already attend
• Identify and test
adult
HIV
care
different models of
to self• 0 additional studies
care to support HIV
management
indentified through • HIV self-management includes
self-management
and adult
PubMed and the
retention and adherence as
among older
care
grey literature
well as other issues such
adolescents
as sexual behavior and selfdisclosure
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transitioning adolescents to self-care and adult HIV clinics. This paucity of data on ALHIV in SSA
is often attributed in part to donor driven reporting requirements that in the past often defined
children as 0–14 years of age and adults as 15 years of age and older (Mburu et al. 2013). In
addition to this general lack of data on ALHIV in SSA, there is even less evidence on the program
approaches that support ALHIV and their families as they cope with retention to care, adhering to
ART, and transitioning into adulthood and self-management.
Some limitations to this review must be noted. The focus of the literature search was on
quantitative data and qualitative studies were not systematically assessed. We also did not
grade the quality of the studies included in this paper, nor did we systematically review the grey
literature.
Despite these limitations the data are clear that disaggregating data by age and gender can
provide powerful and useful insight in the status of and issues confronting adolescents as they
transition through different developmental stages to become adults. Such disaggregation also
highlights the disparities adolescents experience in comparison to adults in remaining in HIV care
and adhering to ART. This information provides a critical foundation for developing a research
agenda that will strengthen our response to and engagement of ALHIV in SSA to improve their HIV
continuum of care outcomes.
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Appendix 2
Meeting Agenda
Project SOAR Technical Advisory Network (TAN) Meeting:
Developing an Implementation Science Research Agenda to
Improve the Treatment and Care Outcomes among
Adolescents Living with HIV in sub-Saharan Africa
18–19 February 2016
Carlyle Hotel, 1731 New Hampshire Ave, NW, Washington, DC 20009
Objectives
• Take stock of the current state of knowledge of the HIV care continuum among adolescents living
with HIV in sub-Saharan Africa.
• Identify priority implementation science research questions that if answered, will contribute to
improving HIV care continuum outcomes among adolescents living with HIV.
• Identify potential study designs and platforms to build upon in answering the priority research
questions.
Day 1
8:00–8:30

Registration and Breakfast (Taylor Room)

8:30–8:45
		
		

Welcome and introductions (Taylor Room)
Julie Pulerwitz, Population Council/Project SOAR
Anouk Amzel, United States Agency for International Development

8:45–9:30
		

Setting the stage: Youth panel (Taylor Room)
Rebecca Marcus, Desmond Tutu HIV Centre, South Africa (facilitator)

9:30–10:15
		
		

A review of the evidence: what do we know about the continuum of care among
ALHIV in sub-Saharan Africa? (Taylor Room)
Julie Denison, Johns Hopkins University, Bloomberg School of Public Health/SOAR

10:15–10:30

Break (Taylor Room)
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10:30–11:45 Expert panel on key challenges and needs of ALHIV (Taylor Room)
		
Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation/SOAR, USA
		(facilitator)
		
Audrey Pettifor, University of North Carolina at Chapel Hill, USA
		
Rebecca Marcus, Desmond Tutu HIV Centre, South Africa
		
Stephen Okoboi, The AIDS Support Organization (TASO), Uganda
		
Harriet Birungi, Population Council, Kenya
		
Susan Kasedde, UNICEF, USA
11:45–12:15 Initial brainstorming of research gaps and ongoing research (Taylor Room)
		Julie Denison
12:15–1:15

Lunch (Taylor Room)

1:15–3:00
Working groups: Identify research questions
		Identifying adolescents living with HIV (HIV testing) and linkages to care:
		
Audrey Pettifor (Taylor Room)
		
Retention in HIV care: Stephen Okoboi (Taylor Room)
		
ART adherence, viral suppression, treatment as prevention:
		
Rebecca Marcus (Ellington Room)
		
Transition to self-management of HIV (including transitioning from pediatric to
		
adult care, acquiring self-disclosure skills, and addressing reproductive and
		
maternal health needs): Harriet Birungi (Horn Room)
3:00–3:15

Break (Taylor Room)

3:15–4:30
		

Working groups: Select six priority research questions and potential
study designs and platforms (Assigned rooms)

Day 2
8:00–8:30

Breakfast (Taylor Room)

8:30–10:00
		

Working groups: Discuss study designs and platforms and finalize
presentations (Assigned rooms)

10:00–10:15

Break (Taylor Room)

10:15–12:15
		
		

Full group: Working groups present priority research questions to all meeting
participants (Taylor Room)
15 mins of presentation and 10 mins of discussion per group

12:15–1:15

Lunch (Taylor Room)

1:15–1:45
		

Full group exercise: Select priority research questions (Taylor Room)
Sara Bowsky, Palladium/SOAR
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1:45–2:15

Feedback on process: Youth perspectives on top priorities (Taylor Room)

2:15–2:45
		
		

Wrap up/reactions (Taylor Room)
Scott Geibel, Population Council/SOAR
Elizabeth Berard, United States Agency for International Development

2:45 		

Adjourn
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Appendix 3
Participant List
Project SOAR Technical Advisory Network Meeting:
Developing an Implementation Science Research Agenda to
Improve the Treatment and Care Outcomes among
Adolescents Living with HIV in Sub-Saharan Africa
18–19 February 2016
Carlyle Hotel, 1731 New Hampshire Ave NW, Washington, DC 20009
Participant name

Organization

Email address

Aaron Lopata

Health Resources and Services
Administration

alopata@hrsa.gov

Adeola Adeyeye

National Institutes of Health

adeola.adeyeye@nih.gov

Aisha Yansaneh

United States Agency for International
Development

ayansaneh@usaid.gov

Alice Armstrong

World Health Organization

armstrongal@who.int

Amanda Geller

Centers for Disease Control and Prevention

xym3@cdc.gov

Ann Kurth

Yale University, School of Nursing

ann.kurth@yale.edu

Anouk Amzel

United States Agency for International
Development

aamzel@usaid.gov

Audrey Pettifor

University of North Carolina at Chapel Hill/
SOAR

apettif@email.unc.edu

Bernadette Ng’eno

Centers for Disease Control and Prevention

uyt0@cdc.gov

Bill Kapogiannis

National Institutes of Health

kapogiannisb@mail.nih.gov

Claude Mellins

Columbia University

cam14@cumc.columbia.edu

Deanna Kerrigan

Johns Hopkins University, Bloomberg School
of Public Health/SOAR

dkerrig1@jhu.edu

Debbie Weiss

Population Council/SOAR

dweiss@popcouncil.org

Donna McCarraher

FHI360/Youth Power

DMccarraher@fhi360.org

Elizabeth Berard

United States Agency for International
Development

eberard@usaid.gov

Elizabeth Lowenthal

University of Pennsylvania

lowenthale@email.chop.edu

Ellen Weiss

Population Council/SOAR

eweiss@popcouncil.org

George Siberry

National Institutes of Health

siberryg@mail.nih.gov
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Gina Dallabetta

The Bill and Melinda Gates Foundation

Gina.Dallabetta@gatesfoundation.org

Harriet Birungi

Population Council

hbirungi@popcouncil.org

Ilana Lapidos-Salaiz

United States Agency for International
Development

ilapidossalaiz@usaid.gov

Jason Bacha

Baylor College of Medicine, Tanzania

bacha@bcm.edu

Joseph Chaila

Zambart, Zambia

mwate@zambart.org.zm

Julie Denison

Johns Hopkins University, Bloomberg School
of Public Health/SOAR

jdenison@jhu.edu

Julie Pulerwitz

Population Council/SOAR

jpulerwitz@popcouncil.org

Katlego Koboto

Baylor, Botswana

ktkoboto@gmail.com

Katongo Konayuma

Zambart, Zambia

kkonayuma05@gmail.com

Kendra Phillips

United States Agency for International
Development

kphillips@usaid.gov

Kevin Osborne

FHI360/LINKAGES

kosborne@fhi360.org

Luyanda Mangaliso
Ncgobo

Desmond Tutu HIV Centre, South Africa

mmangalisoluyandangcobo@gmail.com

Lynne Mofenson

Elizabeth Glaser Pediatric AIDS Foundation/
SOAR

lmofenson@pedaids.org

Melissa Sharer

John Snow Inc/AIDSFree

melissa_sharer@jsi.com

Mwansa Jonathan
Kaunda

Arthur Davison Children’s Hospital, Zambia

jonathankmwansa@gmail.com

Nandita Sugandhi

Clinton Health Access Initiative

NSugandhi@clintonhealthaccess.org

Naomi Rutenberg

Population Council/SOAR

nrutenberg@popcouncil.org

Nokuthula Ndleleni

Desmond Tutu HIV Centre, South Africa

nokuthulandleleni@gmail.com

Paula Vaz

Ariel Glaser Pediatric AIDS Foundation,
Mozambique

pvaz@arielglaser.org.mz

Rachel Vreeman

Indiana University

rvreeman@iu.edu

Rebecca Marcus

Desmond Tutu HIV Centre, South Africa

Rebecca.Marcus@hiv-research.org.za

Sabrina
Bakeera-Kitaka

Makerere University College of Health
Sciences, Uganda

sabrinakitaka@yahoo.co.uk

Sara Bowsky

Palladium/SOAR

Sara.Bowsky@thepalladiumgroup.com

Scott Geibel

Population Council/SOAR

sgeibel@popcouncil.org

Sean Compas

Population Council/SOAR

scompas@popcouncil.org

Sherry Hutchinson

Population Council/SOAR

shutchinson@popcouncil.org

Stephen Okoboi

The Aids Support Organization (TASO),
Uganda

okobois@tasouganda.org

Susan Kasedde

UNICEF

skasedde@unicef.org

Susannah Allison 

National Institutes of Health

allisonsu@mail.nih.gov

Verne Kemerer

Palladium/SOAR

vkemerer@popcouncil.org
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Appendix 4
Prevention of Mother-to-child
Transmission of HIV among ALHIV
USAID requested an additional review be added to this document to examine the published
evidence regarding the prevention of mother-to-child transmission (PMTCT) of HIV among
adolescents living with HIV. This topic is touched upon in the transition to adult care section in the
complete literature review in Appendix 1, but in this section we present a more comprehensive
review of PMTCT among adolescents in sub-Saharan Africa.

METHODS
We conducted a review of the published literature by searching PubMed using terms such as HIV,
adolescent, Africa and prevention of mother-to-child transmission. Abstracts were reviewed and
articles pulled to assess if they met the eligibility criteria including having data on PMTCT outcome
and the study sample was from SSA and had a mean or median age between ages 10 and 19
years. The grey literature was not systematically searched. The results of this process are shown
in the flow chart on the next page (Figure 1).

RESULTS
As noted above in the transitioning to adult care section, evidence is mounting that adolescent
females have worse PMTCT outcomes when compared to adults (Fatti et al. 2015; Horwood et al.
2013) and use maternal health care less frequently when pregnant (Birungi et al. 2011). A 2013
systematic review of the barriers and facilitators of PMTCT in sub-Saharan Africa identified 20
quantitative and 8 mixed-methods studies (Gourlay et al. 2013). Out of these studies, only two
provided data on adolescents 10–19 specifically. A study among women attending ANC services
in Moshi Tanzania found no difference in an adjusted odds ratio between age groups (14–19 year
olds, 20–24 year olds and 25 years and older) in terms of having a male partner attend the ANC
service for HIV testing (Msuya et al. 2008).
The other study was a multi-country study that examined the cord blood of 27,893 women who
had given birth for HIV antibodies, and for those found positive, the presence of nevirapine
(Stringer et al. 2010). Study samples were from Cameroon, Cote d’Ivoire, South Africa and
Zambia. While the median age of participants was 27 years (IQR 23–21) the authors assessed
differences in nevirapine coverage comparing mothers younger than 20 vs. adult women older
than 30 years of age (age range not provided). This analysis found that the teen mothers (aOR
1.44; 95% CI, 1.18–1.76) and mothers 20–24 years of age (aOR 1.28; 95% CI 1.07–1.54) were
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FIGURE 1 Disposition of citations during the PubMed search and screening process for
adolescents and PMTCT
Records excluded (n=78)
Records identified through
Pubmed search (N = 91)

• Ineligible ages of study participants (n = 58)
• Qualitative studies (n = 3)
• Not about ALHIV and PMTCT (n = 16)
• Retracted (n = 1)

Records excluded (n=11)
Full-text articles assessed
for eligibility (n = 13)

• Ineligible ages of study participants (n = 5)
• Qualitative studies (n = 1)
• Not about ALHIV and PMTCT outcomes (n = 5)

Studies included from
Pubmed search (n = 2)

Additional records identified through other
sources (n = 5; 4 studies and 1 systematic
review)

both significantly more likely to experience failed coverage (not provided nevirapine), while there
was no difference in nevirapine coverage between the 26–30 year olds and those older than
30. When provided with nevirapine, there was no difference between mothers younger than 20
compared to those older than 30 in terms of non-adherence to the medication (aOR 1.24; 95% CI
0.83–1.84).
The remaining published studies were found through the PubMed search and by reviewing the
references of eligible articles. A cohort study among HIV-positive pregnant women in South Africa
followed 312 young women (up to age 24 years) of whom 65 were adolescents aged 19 years
or less (Fatti et al. 2015). This multivariable analysis found that adolescents, compared to adult
women age 25 and older, were at greater risk of being unaware of their status, not receiving
lifelong ART by time of delivery and to experience maternal mortality, although the results from
this model should be considered with caution as several variables had perfect 95% confidence
intervals (Fatti et al. 2015). Another study among 9,803 mothers, including adolescent mothers
under 20 years of age, found that the adolescent mothers were more likely to be unaware of
their status (aOR 2.2, 95% 1.5–3.3), and to have dropped out at CD4 count testing or not receive
result (aOR 1.7, 95% CI 1.1–2.7) than mothers over 20 years of age (Woldesenbet et. al 2015).
In another study, 1,059 HIV-positive adolescents in Kenya participated in a quantitative interview,
of whom 393 had ever been pregnant for a total of 506 pregnancies (Birungi et al. 2011).
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Adolescents accessed prenatal care during 84 percent of the 506 pregnancies, but only accessed
PMTCT services during 67 percent of the pregnancies. Overall, less than half of these 393
female adolescents attended four or more prenatal care visits (45 percent). Those who attended
4 or more prenatal care visits, however, compared to their peers who had not, were 6.5 times
more likely to access PMTCT services (95% CI 2.8–15.3), 4.7 times more likely to have a skilled
attendant at birth or during an induced or spontaneous abortion (95% CI 2.4–9.0), and 5.1 times
more likely to receive post abortion/postnatal care (95% CI 2.8–15.3). Overall, adolescents
whose husbands were responsible for the pregnancy were also more likely to access PMTCT
services compared to adolescents impregnated by someone other than a husband (OR 4.9, 95%
CI 1.8–13.1).
In South Africa, 18,363 mothers attending well-child clinics with children six years of age or
younger participated in a cross-sectional survey (Horwood et al. 2013). Out of these mothers,
6,467 self-reported living with HIV - 687 adolescents 12–19 years of age and 5,780 adults
age 20–39. Among these HIV-positive mothers, more adults compared to adolescent mothers
have had a CD4 cell count test during pregnancy (81 percent vs.66.5 percent, p < 0.0001),
received their results (84.4 percent vs. 75.4 percent, p < 0.0001) and had CD4 cell counts <200
(24.5 percent vs. 10.6 percent, p < 0.0001). Both adult and adolescent mothers received ART
prophylaxis (96.2 percent vs. 94.9 percent), however, adolescent mothers were less likely to
receive ART for their own health compared to adult mothers (3.6 percent vs. 14.7 percent, p <
0.0001), and were less likely to receive the full recommended PMTCT regimen (76.7 percent vs.
81.2 percent, p = 0.007). After birth the adolescent mothers were more likely than their adult
counterparts to exclusively breastfeed (58.9 percent vs 50 percent p < 0.0001) and to have a
higher proportion of infected infants (10.8 percent vs. 6.6 percent, OR 1.7, 95% CI 1.2–2.4). This
greater odds in having an HIV infected infant, however, disappeared after controlling for whether
or not a mother received a recommended ART regiment compared to an ineffective regimen. The
authors comment that this finding highlights poor access to service, rather than biological factors,
as an underlying cause in HIV transmission among adolescent mothers and their infants, echoing
findings found in Stringer et al. 2003 presented above.
The last study found that presented data specifically on adolescents living with HIV was a
community cohort study conducted in Kisesa, Tanzania (Gourlay et al. 2015). This study assessed
if women of reproductive age and living with HIV accessed PMTCT or HIV care either before or
during their pregnancy, and if they accessed ART during pregnancy. Out of 9,692 women of
childbearing age in Kisesa who had an HIV test as part of the study survey, 420 were HIV positive
and pregnant resulting in 756 pregnancies. Of these pregnancies, 4.8 percent occurred among
15–19 year old females (n = 36 pregnancies). None of these adolescent mothers, however had
enrolled in HIV care or accessed ART (Gourlay et al. 2015).
The remaining study provides PMTCT related information on adolescents in general. A crosssectional study among 225 pregnant women attending ANC in a primary health care center for
the first time examined PMTCT behaviors in Nigeria by asking “have you ever presented in any
PMTCT center before” and defining utilization as “attendance in any PMTCT service provider
center including voluntary counseling and testing (VCT) prior to presentation for ANC at the
PHC center” (page 3, Amoran, Salami, and Oluwole 2012). This study found that adolescents in
general (not segregated by HIV status) were less likely to have utilized PMTCT services compared
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to older pregnant women (unadjusted OR 0.34, 95% CI 0.1–1.00). This study did not define the
specific ages encompassed by the terms adolescent and older pregnant women.

CONCLUSIONS
The data on PMTCT utilization and outcomes among ALHIV is sparse. As the number of
adolescents living with HIV continues to grow, it is critical to examine reproductive health access
and behaviors in order to fully support ALHIV’s transition into adulthood. The data available,
however, shows a clear gap in reaching adolescent pregnant mothers with PMTCT services. A
few studies even indicate that when an adolescent mother has access to recommended PMTCT
ART regimens, their outcomes do not differ significantly from older women (Horwood et al.
2013; Stringer et al. 2010). These findings highlight the importance of making PMTCT services
accessible for female adolescents and their partners. In addition, none of the studies presented
above provided evidence regarding intervention strategies for engaging ALHIV in PMTCT. Currently
a systematic review/meta-analysis is underway to examine interventions to improved PMTCT
uptake and retention of HIV-infected pregnant and breastfeeding women and their infants
(Ritchie et al. 2015). Such reviews, if they are able to find data on adolescents and to examine
the findings disaggregated by age, may be coupled with our experiences to date with reproductive
health programs among adolescents in general, to inform a research and program agenda to
improve PMTCT access and outcomes among ALHIV.
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